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1. ABSTRACT 
 
 
Mastitis caused by Escherichia coli is common in high-producing cows with a low milk somatic 
cell count. The severity and outcome of E. coli mastitis vary between cows of the same herd and 
between different lactation stages in the same individual. Variation in susceptibility of cows to E. 
coli mastitis and disease severity can be caused by differences in infecting bacteria or cows’ 
immune response. Presence of some virulence factors has previously been reported in mastitis-
causing E. coli bacteria, with serum resistance being the most important one. In early lactation, the 
decreased immune defence of the cow is regarded as the primary reason for increased susceptibility 
to E. coli mastitis. The aim of this thesis was to investigate bacterial and host factors affecting the 
severity and outcome of E. coli mastitis in dairy cows. 
 
To study the bacterial factors in E. coli mastitis, 273 E. coli isolates of clinical bovine mastitis from 
Finland and Israel were studied by polymerase chain reaction to detect the genes for certain 
virulence factors. Serum resistance and capsule formation of the isolates were also examined, as 
these affect the pathogenicity of the strain. The studied isolates possessed a variety of different 
virulence factors, but none of them was common. The detected virulence factors, F17, S and P 
fimbriae, Afa8 afimbrial adhesin, cytotoxic necrotizing factor 1 and 2 (CNF1 and CNF2), 
aerobactin and TraT, formed 29 different combinations, including different groups of serum 
resistance. The association between virulence factors and the severity of the mastitis in affected 
cows was evaluated in Finnish material; none of the virulence factors found from the isolates was 
associated with the severity of clinical signs. However, presence of genes for S and P fimbriae, 
CNF1 and CNF2 was significantly related to persistence of mastitis. This supports the earlier 
findings suggesting that chronic or recurrent E. coli mastitis could be caused by an udder-adapted 
strain of E. coli. The results indicate that to infect the bovine udder, specific virulence factors, e.g. 
those enhancing adhesion or invasion in the epithelia or damaging host cells, are not necessary for 
the E. coli bacteria and that the virulence factors of the infecting bacterial strain probably play a 
minor role in the severity of clinical signs of E. coli mastitis. 
 
A total of 200 of the E. coli isolates were also tested for antimicrobial resistance. Resistance was 
low; 27% of the isolates were resistant to one or more antimicrobial agents and 11% were 
multiresistant. All but one multiresistance pattern included resistance to tetracycline, which is often 
related to resistance to other antimicrobials. We also found an association between resistance for 
some antimicrobials and presence of certain virulence factors. Tetracycline resistance was 
associated with presence of S and P fimbriae, CNF1, CNF2, aerobactin and TraT, resistance to 
ampicillin with aerobactin and resistance to dihydrostreptomycin with CNF2, F17 and aerobactin. 
These associations may cause selection of virulence factors or maintenance of antimicrobial 
resistance. 
 
To study cow factors and host response, we used an experimental E. coli endotoxin model in which 
nine cows were challenged twice, in early lactation (EL) and in late lactation (LL). Cows showed a 
significantly more severe response in the EL than in the LL period. The difference was seen in 
systemic signs, whereas local signs were similar for both periods. The concentration of tumour 
necrosis alpha (TNFα) in milk increased after the endotoxin challenge, reaching higher levels in EL 
cows. No TNFα was detected in blood. Although TNFα might not be directly responsible for the 
systemic signs in endotoxin mastitis, it probably has a critical role in initiating host response by 
inducing the local production of other cytokines, which in turn mediate the systemic effects of the 
host response. TNFα also seems to induce production of serum amyloid A (SAA) in milk, as milk 
SAA concentration was higher in EL than in LL, and the concentrations of TNFα and SAA were 
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closely related at the cow level. In blood, the SAA increased later, after endotoxin challenge, with 
the average concentration being higher in LL, indicating differences in production and regulation of 
local and systemic SAA.  
 
After induction of endotoxin mastitis, the number of polymorphonuclear leucocytes (PMN) in milk 
and blood increased faster, reaching higher levels in the EL than in the LL period. However, the 
function of blood neutrophils after endotoxin challenge, measured as chemiluminescence (CL), 
increased in LL but decreased in EL. This impaired function of blood PMN in EL could be caused 
by subclinical ketosis of the cow, reflected in the increased serum free fatty acid concentrations. 
The CL of milk PMN increased in both EL and LL, being more pronounced in EL and appearing 
simultaneously with the decreased CL of PMN in blood. This may have resulted from an influx of 
the most active PMN from the circulation to the milk, and from the stimulation of the milk PMN by 
such locally produced cytokines as TNFα. The function of PMN may though be more critical for 
host defence and for susceptibility of cows to E. coli mastitis than their actual number in blood and 
milk. 
 
The results of this thesis supports the findings of previous studies showing that the increased 
susceptibility of the cow to E. coli mastitis and the more severe course of disease in early lactation 
depends more on host factors than on the characteristics of the infecting bacterial strain. The 
virulence and antimicrobial resistance of mastitis-causing E. coli reflect the situation of bacteria 
found in the environment or in the intestines or faeces of the cow. To prevent E. coli mastitis, 
efforts should be focused on improving the cows’ environment and herd management.  
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3. ABBREVIATIONS 
 
 
AER aerobactin 
APP acute-phase proteins 
ASAT  serum aspartate aminotransferase  
AU  arbitrary units  
CL chemiluminescence  
CNF1 cytotoxic necrotizing factor 1  
CNF2 cytotoxic necrotizing factor 2  
DHS  dihydrostreptomycin  
EGTA-BS bovine serum with inactivated classical complement pathway  
EL  early lactation  
ELISA enzyme-linked immunosorbent assay  
FFA free fatty acids  
I-BS inactivated bovine serum  
IL interleukin 
LBP LPS-binding protein 
LL late lactation 
LPS lipopolysaccharide 
LT  heat-labile enterotoxin 
mCD14 membrane CD14 
MIC  minimal inhibitory concentration  
MIC50  minimal inhibition concentration for 50% of isolates tested  
MIC90  minimal inhibition concentration for 90% of isolates tested 
MMP matrix metalloproteinase 
MXP  multiplex PCR 
NAGase N-acetyl-β-D-glucosaminidase 
N-BS normal bovine serum  
PC post-challenge 
PCR  polymerase chain reaction  
PCV packed cell volume  
PMN polymorphonuclear leucocytes 
PP  post-partum  
ROS  reactive oxygen species  
SAA serum amyloid A  
SCC somatic cell count  
sCD14 soluble CD14 
ST heat-stable enterotoxin 
TNFα  tumour necrosis factor alpha 
TS trimethoprim-sulphadiazine  
TSA trypticase-soy agar  
WBC  white blood cell  
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4. INTRODUCTION  
 
 
Environmental mastitis caused by Escherichia coli has increased in many countries and herds at the 
same time as contagious mastitis has been successfully controlled (Lam, 1996b; Peeler et al., 2002). 
The proportion of E. coli as a causative agent in bovine clinical mastitis varies between countries. In 
Finland less than 20% (Pyörälä and Pyörälä, 1998; Nevala et al., 2004), whereas in Israel more than 
60% (Shpigel et al., 1998) of clinical mastitis is caused by coliforms. The severity of the disease 
also varies between countries; E. coli mastitis is seldom very serious or fatal in Finland, whereas in 
Israel up to 16% of coliform mastitis cases result in the death or culling of the cow (Shpigel et al., 
1994).  
 
E. coli infects the udder via the teat canal (Eberhart, 1984). An environment contaminated with 
faeces is the main source of mastitis-causing E. coli bacteria (Linton et al., 1979; Nemeth et al., 
1994). Environmental factors, herd management and use of antimicrobial agents may select 
bacterial strains and affect their virulence factors and antimicrobial resistance, causing the variation 
in the course of E. coli mastitis seen between countries and herds. Poor barn design and 
management of dairy cows may also provide the cows with predisposing factors for coliform 
mastitis (Ward et al., 2002; Krause et al., 2003).  
 
The severity and outcome of E. coli mastitis can vary between cows in the same herd and in the 
same individual during different lactation stages. The observed systemic and local clinical signs 
result from the acute-phase reaction, which is the response of the host to any tissue injury caused by 
trauma or inflammation (Kushner, 1984; van Miert, 1991). The acute phase reaction differs 
depending on the physical condition of the individual. Physiological stress around parturition and 
metabolic diseases, for instance, may be associated with increased susceptibility of periparturient 
cows to coliform mastitis (Suriyasathaporn et al., 2000; Burvenich et al., 2003). Studies on 
spontaneous or experimental E. coli mastitis have shown that affected cows can be divided into 
mild or severe responders based on clinical signs and disease outcome (Pyörälä et al., 1994; 
Hirvonen et al., 1999; Wenz et al., 2001a). Periparturient and EL cows most frequently show severe 
clinical signs and even fatal outcome (Hill et al., 1979; Pyörälä and Pyörälä, 1998; Menzies et al., 
2000).   
 
In field cases, the onset of mastitis is unknown and the time of detection may affect the definition of 
severity. On a practical level, the most important issues are prevention, treatment and outcome of 
mastitis. It is generally agreed that the treatment of E. coli mastitis may be adjusted according to the 
severity of disease; only severely affected or immunosuppressed cows require aggressive treatment, 
including antimicrobial agents. It is important for the veterinary practitioner or the herd manager to 
be able to identify these cases based on severity of clinical signs and to be aware of the link 
between clinical signs and E. coli mastitis outcome. 
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5. REVIEW OF THE LITERATURE 
 
 
5.1. CLINICAL CHARACTERISTICS AND OUTCOME OF E. COLI MASTITIS 
Despite the numerous studies carried out on mastitis caused by Escherichia coli, many open 
questions remain concerning the pathogenesis and clinical course of the disease. When studying the 
aspects affecting severity of E. coli mastitis, the first problem encountered centres around the 
definition of the term severity; it can be based on clinical signs or outcome of mastitis (Pyörälä et 
al., 1994; Shpigel et al., 1994; Dosogne et al., 1997; Hirvonen et al., 1999; Wenz et al., 2001a). The 
intensity of clinical signs reflects host response at the time of observation, and varies during the 
course of mastitis. The final outcome, as rapid elimination of bacteria, prolonged infection or death 
of the cow due to endotoxin shock, describes more the ability of the cow to limit deleterious 
inflammatory reactions and to clear the infection (Burvenich et al., 2003). The host response may be 
more aggressive because of a particularly virulent bacterial strain invading the udder or a vast 
number of bacteria, which results in large amounts of released endotoxin. Host response may also 
be intense in a case of a more alert immune system.  The outcome may become serious or fatal if 
the cow’s immune system can not kill the bacteria due to their high virulence or excessive number, 
or an impairment of the immune system. Serious consequences may also occur if the cow’s immune 
system is not suppressed after the bacteria have been cleared from the udder.  
 
Different methods have been introduced for classifying the clinical course of E. coli mastitis. Cows 
can be divided into severe or mild responders based on intensity of general and local clinical signs, 
changes in appearance of milk and loss of milk production during mastitis (Pyörälä et al., 1994; 
Dosogne et al., 1997; Hirvonen et al., 1999; Wenz et al., 2001a). Cows can also be grouped by 
outcome or the ability to return to production (Shpigel et al., 1994). In experimental mastitis, the 
severity of some clinical signs, such as heart rate and rumen motility, have been shown to correlate 
with a high number of bacteria in the milk and with loss of milk production (Lohuis et al., 1990b). 
 
The clinical characteristics and outcome of E. coli mastitis vary from mild mastitis, where cows 
have only local signs in the udder and the duration of the infection is short, to very severe or even 
fatal forms (Burvenich et al., 2003). E. coli mastitis typically has a sudden onset, which leads to 
changes in milk appearance, first to serous and yellow, and later to clotty and thick. Milk somatic 
cell count (SCC) increases to very high numbers. The udder becomes hard, swollen and tender. The 
cow also has systemic signs, generally including high fever, increased pulse frequency, reduced 
rumen contractions, lack of appetite, depression and decreased milk production. Studies using 
experimental E. coli mastitis models have shown that the first signs are usually noticed at the local 
level, at approximately 8 h post-challenge (PC), and fever and other systemic signs peak at 12 h PC 
(Lohuis et al., 1990b; Hirvonen et al., 1999; Hoeben, 1999; Haddad et al., 2001). In mild or 
moderate cases, the systemic signs vanish within 48 h and local signs within 7 days (Lohuis et al., 
1990b; Pyörälä et al., 1994; Hirvonen et al., 1999). In severe cases, the cow may not survive or 
systemic signs may be prolonged, with milk production being lost permanently (Shpigel et al., 
1998; Hirvonen et al., 1999; Rantala et al., 2002). 
 
In experimental E. coli mastitis, bacteria can be detected in the milk until 5-7 days after inoculation; 
endotoxin is simultaneously detected (Pyörälä et al., 1994; Dosogne et al., 2002). However, a large 
variation exists in the duration of infection between experimental studies due to the different 
bacterial strains and doses used in the challenge. Bacteraemia or endotoxaemia occur seldom and 
only in very severe cases (Katholm and Andersen, 1992; Wenz et al., 1999; Wenz et al., 2001b; 
Dosogne et al., 2002). Bacteraemia was found significantly more often in cows with severe clinical 
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signs (Wenz et al., 2001b). Only trace amounts of endotoxin have been detected sporadically in the 
blood of cows with experimental E. coli mastitis (Dosogne et al., 2002). The release of 
inflammatory mediators, rather than the absorption of endotoxin, causes the systemic signs of E. 
coli mastitis (Verheijden et al., 1983; Lohuis et al., 1988; Burvenich et al., 2003). 
 
 
5.2. E. COLI BACTERIA 
E. coli is a Gram-negative, non-spore-forming rod, which belongs to the family Enterobacteriaceae. 
The cell wall of Gram-negative bacteria typically consists of three layers, the cytoplasmic 
membrane and the outer membrane, separated by a peptidoglycan layer (Figure 1). The outer cell 
membrane contains phospholipids, membrane proteins and lipopolysaccharide (LPS). LPS 
comprises lipid-A, the lipopolysaccharide core and repeated polysaccharide units called O-antigens 
(Figure 1) (Cullor, 1996). Lipid-A is the lipophilic, inner part of LPS. The toxic effects of LPS also 
known as endotoxin, are caused by lipid-A (Cullor, 1996; Hogan and Smith, 2003). Here, the terms 
LPS and endotoxin are used synonymously. On the outer surface, bacteria may have fimbrias which 
protrude from the cell wall. The surface may be covered with a thick polysaccharide layer called a 
capsule. Based on the different antigenic structures of O-antigens, K-antigens (capsular) and H-
antigens (flagellar), E. coli strains can be divided into O:H:K serotypes (Cullor, 1996). 
 
 
 
Figure 1. Schematic illustration of the components of Gram-negative bacteria (Redrawn from Cullor, 1996). 
 
Escherichia coli is part of the normal intestinal flora of humans and animals. It is the most common 
facultative anaerobic bacterial species in the gut and is constantly excreted in the faeces to the 
environment. Pathogenic E. coli bacteria can cause intestinal and extraintestinal infections in 
mammalian and avian hosts (Cullor, 1996). Infections of the gastrointestinal tract may lead to 
various kinds of diarrhoeic diseases, which, in the case of shiga toxin, may even progress to 
systemic haemolytic ureamic syndrome in humans and oedema disease in pigs (Cullor, 1996). E. 
coli is the predominant cause of urinary tract infection in humans. E. coli also causes invasive 
diseases, such as bacteraemia and meningitis, in humans and animals. In avian species, E. coli is an 
important cause of respiratory and ovarian tract infections (Cullor, 1996). 
 
 
5.2.1. Virulence factors 
Pathogenic E. coli bacteria are typically specific to the type of disease they cause and to the animal 
species infected. They produce virulence factors involved in pathogenesis of specific diseases 
(China and Goffaux, 1999). Bacterial virulence factors are required to colonize and infect the host 
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and to fight host defence mechanisms. Major groups of E. coli virulence factors include toxins, 
adhesins, proteins secreted into host cells, polysaccharide capsules and O-antigens, and other 
mechanisms to resist killing by complement or to scavenge iron. Bacteria do not produce virulence 
factors constantly but only upon receiving certain signals from the host or environment (China and 
Goffaux, 1999). The genes for virulence factors may be present in the bacterial genome or may 
reside extrachromosomally on plasmids, even though the virulence factor is not produced (Harel 
and Martin, 1999).  
 
 
5.2.1.1. Adhesins 
Adhesins are either hair-like appendages known as fimbriae or pili, or afimbrial adhesins associated 
with the cell surface (Soto and Hultgren, 1999). Bacteria need adhesins to adhere to and colonize 
the host cell surface. Different adhesins have been detected in E. coli isolates associated with 
bovine diseases. The family of F17 fimbriae includes F17a expressed by bovine enterotoxigenic E. 
coli, F17b expressed by E. coli isolated from septicaemic and diarrhoeic calves and lambs, F17c 
isolated from septicaemic E. coli strains and F17d described in bovine enterotoxigenic E. coli and 
E. coli isolated from diarrhoeic calves (Le Bouguenec and Bertin, 1999). The F17 fimbriae are often 
associated with other virulence factors in pathogenic E. coli. Genes encoding F17 fimbriae are 
located on the chromosome (Bertin et al., 1996). In the study of Pohl and Mainil (1995), almost half 
of the F17-positive E. coli strains were resistant to complement and produced aerobactin.   
 
S and P fimbriae are usually found in E. coli strains causing urinary tract infection (Soto and 
Hultgren, 1999). They are probably needed for adherence of bacteria to urinary tract epithelia and 
are suggested to be involved in recurrent urinary tract infections (Schilling et al., 2001). Genes 
encoding S and P fimbriae are located on the chromosome (Mainil et al., 1997). 
 
Afimbrial adhesins are encoded by different afa genes; afa-7 and afa-8 have been found in bovine 
isolates, afa-8 being more common than afa-7 (Lalioui et al., 1999). Afa-8 genes have been detected 
on plasmids, which also carried genes for F17c and cytotoxic necrotizing factor 2 (CNF2) (le 
Bouguenec and Bertin, 1999). Another afimbrial adhesin found in bovine pathogenic E. coli strains 
is the capsule-like structure called CS31A adhesin (le Bouguenec and Bertin, 1999). It has been 
described in E. coli strains from calves with septicaemia or diarrhoea (Contrepois et al., 1986; 
Mercado et al., 2003). The genes encoding CS31A have been detected on large plasmids carrying 
genes for other virulence factors, such as aerobactin and F17c fimbriae, as well as for antimicrobial 
resistance (Contrepois et al., 1986). 
 
 
5.2.1.2. Toxins 
Pathogenic E. coli strains may produce a variety of toxins with different activities: heat-labile (LT) 
and heat-stable (ST) enterotoxins, shiga toxins and cytotoxic necrotizing factors 1 and 2 (CNF1 and 
CNF2). Shiga toxins are produced by enterohaemorrhagic E. coli strains (Riley et al., 1983). 
Enterotoxigenic strains usually produce two enterotoxins, LT and ST, which have distinct roles in 
the pathogenesis. E. coli isolates producing CNF2 are common in cattle (Pohl et al., 1993). Many of 
these strains also produce F17b fimbriae and aerobactin and are resistant to the killing action of 
serum. The CNF1-positive strains are typically isolated from extraintestinal infections and are 
mainly positive for adhesins of the P and S fimbrial families or the Afa family (Mainil et al., 1997, 
1999; Bertin et al., 1998). The production of CNF1 is chromosomally encoded, whereas CNF2 is 
encoded by genes located on a plasmid (Falbo et al., 1992; Mainil et al., 1999). 
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5.2.1.3. Aerobactin 
Iron is an essential element for the survival and multiplication of E. coli. Aerobactin is one of the 
siderophores present in Gram-negative bacteria. It chelates iron, making it available for bacterial 
use. The gene for aerobactin is located either on a chromosome or on a plasmid, where many of the 
antimicrobial resistance genes are also located (Vidotto et al., 1991; Johnson et al., 2002).  
 
 
5.2.1.4. Factors conferring serum resistance 
Serum resistance is one of the most studied virulence properties of Gram-negative bacteria (Table 
1). Resistance to the killing action of serum is linked to structures at or near the bacterial surface. 
Capsule or outer membrane proteins, like OmpA and TraT, have been suggested to interfere with 
complement components and the membrane attack complex, preventing the killing action (Ward 
and Sebunya, 1981; Taylor, 1983; Weiser and Gotschich, 1991; Pramoonjago et al., 1992). 
 
TraT is a cell surface-exposed lipoprotein, which is assumed to inhibit the correct assembly or 
membrane insertion of the membrane attack complex of complement (Sukupolvi and O’Connors, 
1990). TraT is encoded by the traT gene carried on large conjugative plasmids (Sukupolvi and 
O’Connors, 1990). The K1 capsular antigen protects E. coli from the killing effect of serum and has 
been thought to co-operate with TraT (Montenegro et al., 1985) However, in clinical studies 
(Nemeth et al., 1991; Wooley et al., 1993; Pfaff-McDonough et al., 2000), no relation of K1 to 
serum resistance or the traT gene could be detected. 
 
 
5.2.2. Pathogenicity of E. coli isolated from mastitis 
E. coli is an opportunistic bacterium when causing mastitis (Valente et al., 1988; Barrow, 1989; 
Nemeth et al., 1994). Bovine mastitis resembles urinary tract infection; the infection in both is 
ascending and caused by bacteria from the environment. The source of mastitis-causing E. coli 
strains may be found in the intestinal flora of the affected cow (Linton and Robinson, 1984), other 
cows or calves. Several different serotypes have been detected from the isolates causing mastitis, 
and E. coli mastitis is definitely not caused by a limited number of specific pathogenic strains 
(Linton et al., 1979; Linton and Robinson, 1984; Sanchez-Carlo et al., 1984b; Valente et al., 1988; 
Lipman et al., 1995; Jung, 1999). However, the existence of udder-adapted E. coli strains has been 
suggested, since the same serotype (Hill et al., 1979; Linton and Robinson, 1984) and genotype of 
E. coli have been isolated from cases of recurrent mastitis (Lipman et al., 1995; Lam et al., 1996a; 
Döpfer et al., 1999; Bradley and Green 2001). Isolates from recurrent mastitis have been shown to 
invade mammary epithelial cells in vitro faster and in larger numbers than the strains from 
occasional cases (Döpfer et al., 2000). Mastitis-causing E. coli strains may also have some common 
virulence factors to support their colonization, adherence and survival in the udder.  
 
Serum resistance of E. coli has been studied since in the early days of mastitis research (Carroll and 
Jasper, 1977). In the previous studies, most of the isolates have been serum-resistant, although 
serum-sensitive strains have occasionally also been found (Sanchez-Carlo et al., 1984a; Valente et 
al., 1988; Barrow and Hill, 1989; Nemeth et al., 1991, 1994; Fang and Pyörälä, 1996). An 
experimental study by Carroll et al. (1973) showed that serum-resistant isolates caused longer and 
more severe E. coli mastitis than serum-sensitive strains, and serum-sensitive strains were even 
unable to cause clinical mastitis (Carroll et al., 1973). The lactation stage of the affected cow had no 
effect on serum resistance patterns of isolated organisms (Hogan et al., 1989). 
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Table 1. Prevalence of the previously studied virulence factors in E. coli isolated from mastitis. 
 
Positive  Type of the study 
Reference 
No. of 
isolates Virulence factor studied No. %  
Geno-
type 
Pheno-
type 
        
Caroll and Jasper, 1977 ? Serum resistance  100   x 
Wray et al., 1983 95 Haemagglutination 10    x 
  Colicin V 3    x 
 71 K-antigen 41    x 
Sanchez-Carlo et al., 1984 184 Serum resistance 183 99,5   x 
  ST 1    x 
  LT 2    x 
  Invasiveness 0    x 
Valente et al., 1988 65 Serum resistance 65 100   x 
  ST 0 0   x 
  LT 0 0   x 
Barrow and Hill, 1989 237 Serum resistance 230 98,7   x 
  Haemagglutination 203 86   x 
  Colicin 37 18   x 
  Colicin V 10    x 
  Vero toxin 1 0,5   x 
  Capsule 172 75   x 
Nemeth et al., 1991 95 Serum resistance 61 64   x 
  TraT 41 43  x  
  K1 3 3   x 
Pohl et al., 1993 29 CNF1 6   x  
  CNF2 1   x  
Nemeth et al., 1994 50 Serum resistance  76   x 
  Aerobactin  20   x 
  Colicin  14   x 
  Colicin V  6   x 
  Vero toxin  8   x 
Lipman et al., 20 F17 11 55  x  
  CNF1 1   x  
Burns et al., 1996 62 CNF1 1 1,6   x 
  CNF2 0 0   x 
Fang and Pyörälä, 1996 169 Serum resistance 102 68   x 
Stephan and Kuhn, 1999 145 VT1 1   x  
  VT2 1   x  
  VT1 and VT2 2   x  
  eae 0   x  
  ehly 4   x  
  S and P fimbriae 2    x 
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Numerous virulence factors have been described among mastitis-causing E. coli isolates, but none 
of them has proven to be common (Table 1). The phenotypic methods used in most of the earlier 
studies might not always detect virulence factors since bacteria may produce them only under 
conditions in which they are necessary for bacterial survival.  
 
 
5.2.3. Antimicrobial resistance 
Broad-spectrum antimicrobial agents are generally used to treat coliform mastitis (Andersson, 1989; 
Erskine et al., 2002b), despite no convincing evidence exist of their benefit in treatment (Erskine et 
al., 1992; Pyörälä et al., 1994; Pyörälä and Pyörälä, 1998; Erskine, 2000). The use of antimicrobial 
agents causes selection pressure towards antimicrobial resistance among bacteria (Aarestrup, 1999; 
Prescott, 2000). Many of the genes encoding antimicrobial resistance are located in large 
conjugative plasmids (Falkow, 1975), and they may be linked together forming multiresistance 
(Levy et al., 1976; Prescott, 2000). The genes encoding the production of some virulence factors are 
also carried by plasmids and may be linked to the antimicrobial resistance genes in these plasmids 
(Hirsh et al., 1993). The antimicrobial resistance patterns of the bacterial population in the cows’ 
environment can vary between countries or even between herds, reflecting the quantitative and 
qualitative aspects of antimicrobial treatments (Aarestrup, 1999; Anonymous 2001; Österbland et 
al., 2001). The use of antimicrobials may therefore also select bacteria with virulence factors linked 
to the antimicrobial resistance.  
 
Antimicrobial resistance of E. coli isolates from bovine mastitis has been studied earlier by several 
authors (Bishop et al., 1980; Sogaard, 1982; Anderson, 1989; Trolldenier, 1995; Erskine et al., 
2002b). Results have varied greatly, which may partly be due to the different methods and break-
points used to determine susceptibility.  
 
 
5.3. HOST RESPONSE 
Host response is a complicated process in which the non-specific and specific immune systems act 
together to attack and destroy the invading pathogen and repair the damage the pathogen or the 
immune system itself has caused to the host (van Miert, 1995; Burvenich et al., 2003).  
 
The first host defence against invading bacteria is the physiological barrier of the teat canal. Tight 
and rapid closure after milking and during the dry period prevents influx of bacteria. After invading 
the udder, the bacteria have to deal with humoral factors present in milk. During the dry period a 
high concentration of lactoferrin is one of the most effective factors against infections caused by 
coliform bacteria. Lactoferrin chelates iron and prevents growth of coliforms, which require large 
amounts of iron. In the lactating period, the concentration of lactoferrin in normal milk is not high 
enough to work efficiently, and the elevated citrate concentration further interferes with it (Kremer 
et al., 1990). During the middle of dry period the cow is thus quite resistant to clinical E. coli 
mastitis. However, in early and late dry period there may be acquisition of new E. coli infections, 
which become clinical during the first 100 days of lactation (Bradley and Green, 2000). 
 
The bacteria killing ability of serum is thought to be an important defence mechanism against E. 
coli. The serum killing effect is based on complement and its ability to cause lysis of bacteria. The 
complement system also enhances PMN phagocytosis by attracting phagocytes, opsonizing bacteria 
and priming the intracellular killing of phagocytes (Rainard, 2003). The origin of complement 
components in bovine milk probably differs between normal and mastitic milk. In normal milk, the 
transudation of liver-produced complement proteins from the serum and the local synthesis of  C3 
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may dominate (Rainard, 2003). Moreover, in this milk, the killing function of the complement may 
not be as important as previously thought since the amount of some complement compounds is low 
and other components of milk interfere with the complement (Kremer at al. 1990; Rainard, 2003). 
During inflammation the vascular permeability increases, causing exudation of complement 
proteins from serum, and the local synthesis by macrophages is simultaneously stimulated by 
proinflammatory cytokines (Rainard, 2003). This results in a different composition and a higher 
amount of complement proteins in milk, enhancing the bactericidical activity. 
 
The most important defence mechanism against invading bacteria is the acute-phase response, 
which in E. coli mastitis is initiated by endotoxin released from bacteria (Olson et al., 1995). A 
great number of cytokines are produced by mammary macrophages, epithelial and endothelial cells 
and polymorphonuclear leucocytes (PMN) during the inflammatory process. The cytokines have 
various effects in initiating, mediating and reducing inflammation. In E. coli mastitis, the released 
endotoxin is bound by LPS-binding protein (LBP), and recognition of this complex is done by the 
membrane CD14 (mCD14) receptor of monocytes, macrophages and neutrophils, which are present 
in milk, causing the release of tumour necrosis factor alpha (TNFα) (Kielian and Blecha, 1995; 
Paape et al., 2003; Wang et al., 2003). The soluble CD14 (sCD14) may also bind endotoxin, either 
directly or by binding the endotoxin–LBP complex (Bannerman, et al., 2003; Paape et al., 2003; 
Wang et al., 2003). The endotoxin-LBP-sCD14 complex is recognized by the Toll-like receptors on 
the epithelial and endothelial cells of the mammary tissue, causing secretion of chemoattractants 
(Paape et al., 2003). Cytokines, interleukines (IL) and chemoattractants in turn act both locally and 
systemically, attracting neutrophils from the circulation to the infection site, opsonizing the 
pathogen and inducing production of acute phase-proteins (APP) in the liver (Hoeben et al., 2000a; 
Paape et al., 2003). After starting the acute-phase reaction, the speed of PMN efflux to milk and 
their ability to phagocytose the bacteria are critical to the development of mastitis (Burvenich et al., 
1994). If the acute-phase reaction or bacteria killing ability of PMN is reduced, bacteria are able to 
multiply, and the damage caused to the host cells increases. On the other hand, an over-reaction in 
the acute phase may also cause damage so the inhibiting and repairing actions of the acute-phase 
reactions have to be in balance (Burvenich et al., 2003). 
 
Differences in the production, function and kinetics of cytokines and APP may partly explain the 
variation in local and systemic signs of individual animals with E. coli mastitis (Hill et al., 1979; 
Pyörälä and Pyörälä, 1998; Hirvonen et al., 1999; Blum et al., 2000; Menzies et al., 2000; Ohtsuka 
et al., 2001).  
 
 
5.3.1. Neutrophil function 
In a healthy udder, the number of PMN in milk is low, < 100 000 cells/ml (Pyörälä, 2003). After 
any damage caused by bacteria or other pathogens or by physical injury, the number of PMN 
increases dramatically. This increase is mediated by a chemoattracting stimulus, and the degree of 
the stimulus depends on the infecting pathogen. In E. coli mastitis, a high number of PMN is 
required at the infection site immediately, and mature circulating PMN present in blood migrate 
towards the infection site, leading to neutropenia. If the chemoattracting stimulus continues, the 
reserve pool of mature PMN, located in blood vessels and in bone marrow, moves into the 
circulation and then to the infection site. 
 
Immature PMN are seldom normally present in bovine blood (Paape et al., 2003). They are seen if 
neutropenia, caused by migration, is corrected by the release of immature PMN from the bone 
marrow. PMN are produced in the bone marrow by granulopoiesis. Maturity of PMN has an impact 
on their function (Dosogne, 1998; Mehrzad, 2002a; Burvenich et al., 2003); immature PMN have 
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impaired phagocytosis as well as decreased production of reactive oxygen species (ROS). Their 
migration to the infection site is also slower. Migration of PMN from blood circulation to the 
infection site depresses their functions; these cells have decreased phagocytosis because the 
migration utilizes the PMN energy sources. Ingestion of fat and other milk compounds also 
interferes with phagocytosis. The most important factor in intramammary defence against invading 
pathogens are the resident PMN (Burvenich et al., 1994). 
 
PMN recognize the pathogen with the help of complements and other opsonizing factors. After 
recognition, they are able to use two different mechanisms for killing invading bacteria: oxidative-
dependent and oxidative-independent mechanisms. The oxidative-independent mechanisms involve 
a variety of different enzymes and proteins in the non-azurophilic granules of PMN, such as 
lactoferrin, lysozyme, cytosine, elastase and fibronectin, which inhibit the growth of E. coli bacteria 
(Burvenich et al., 2003; Paape et al., 2003). Production of lactoferrin by PMN is, however, minimal 
compared with that by mammary tissue (Pfaffl et al., 2003).  
 
A more effective mechanism against E. coli bacteria is, however, the oxygen-dependent 
mechanism. It takes place when the plasma membrane of the PMN recognizes the bacteria and 
releases superoxide (O2-) and hydrogen peroxide (H2O2) in a respiratory burst (Mehrzad et al., 
2002a; Paape et al., 2003). The oxygen-dependent mechanisms, which reside in the azurophilic 
granules of PMN, also involve the release of other ROS and nitrogen oxide after activation of 
myeloperoxidase during phagocytosis (Burvenich et al., 2003; Paape et al., 2003). ROS production 
of PMN can be measured by chemiluminescence (CL), which reflects the bactericidal capacity 
(Hoeben, 1999; Mehrzad et al., 2001a). 
 
Low initial numbers of PMN, their immaturity and poor function in blood (Lohuis et al., 1990a; 
Vandeputte-Van Messom et al., 1993; Dosogne et al., 1997) as well as a low somatic cell count 
(SCC) in milk (Shuster et al., 1996) correlate negatively with the severity of induced E. coli 
mastitis. 
 
 
5.3.2. Tumour necrosis factor alpha 
TNFα belongs to the proinflammatory and inflammatory cytokines released from cells during 
inflammation (Shuster et al., 1996; Persson Waller et al., 1997). The role of TNFα in the 
pathogenesis of E. coli mastitis has been studied widely. It is supposed to have a pivotal role in 
initiating the effects of endotoxin during E. coli mastitis. TNFα also causes systemic effects, seen in 
changes in hormone secretion, milk production and composition, inflammatory parameters and 
clinical signs (Kushibiki et al., 2003). Some studies have found a correlation between severity of 
response and concentrations of TNFα in blood or milk (Hirvonen et al., 1999; Blum et al., 2000; 
Hisaeda et al., 2001; Ohtusaka et al., 2001), while other studies have reported no direct correlation 
(Nakajima et al., 1997; Hoeben et al., 2000a). TNFα also affects PMN functions by increasing the 
size of PMN and enhancing oxidative burst activity (Paape et al., 2003). However, if excessive 
quantities of TNFα are produced, numerous harmful effects will follow, including reduced blood 
pressure and tissue perfusion, intravascular thrombosis and severe metabolic disturbances, often 
leading to lethal shock (Bemelmans et al., 1996).  
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5.3.3. Serum amyloid A 
In cattle, serum amyloid A (SAA) is a sensitive APP (Boosman et al., 1989; Alsemgeest et al., 
1994; Hirvonen et al., 1999; Horadagoda et al, 1999; Heegaard et al., 2000; Karreman et al., 2000). 
It has also been shown to reflect the severity of mastitis (Eckersall et al., 2001). Cows with clinical 
mastitis have been reported to have increased levels of SAA in serum and milk compared with 
healthy cows (Eckersall et al., 2001; Pedersen et al., 2003); high levels have also been found in 
bovine colostrum (McDonald et al., 2001). SAA is mainly produced in the liver but also 
extrahepatically by macrophages, endothelial cells, mammary epithelial cells and smooth muscle 
cells (Jensen and Whitehead, 1998; Uhlar and Whitehead, 1999; Eckersall et al., 2001; McDonald et 
al., 2001). Extrahepatically produced SAA consist of multiple isoforms (Alsemgeest et al., 1995); 
M-SAA3 is present in normal milk and colostrum (McDonald et al., 2001). The effects of SAA may 
differ locally and systemically and may be concentration-dependent (Uhlar and Whitehead, 1999). 
Local and systemic production of SAA may also be governed by different control mechanisms 
(Eckersall et al., 2001).  
 
 
5.3.4. Effect of age and lactation stage 
The clinical response and outcome of E. coli mastitis vary according to the age of the animal and 
the stage of lactation (Hill et al., 1979; van Werven et al., 1997; Pyörälä and Pyörälä, 1998; 
Mehrzad et al., 2002b). Older cows are more susceptible to E. coli infections because of diminished 
PMN functions (Mehrzad et al., 2002b). It has been shown that E. coli intramammary infections can 
originate from the late dry period and become clinical in early lactation (Bradley and Green, 2000). 
Peracute E. coli mastitis with severe clinical signs most frequently occurs during the periparturient 
period and in early lactation (Hill et al., 1979; Pyörälä and Pyörälä, 1998; Menzies et al., 2000). 
This is thought to be due to the compromised immune mechanisms of the cows during the 
peripartum period (Mehrzad et al., 2001b).  
 
A compromised immune system may result for several reasons. The numbers of circulating PMN in 
the blood change according to lactation stage; they increase at parturition but then decrease rapidly 
during the puerperal period, reaching a lower level than seen in later lactation (Kehrli et al., 1989; 
Zerbe et al., 2000; Kulberg et al., 2002). Cortisol levels may affect the number and function of 
PMN, and a positive correlation between PMN and cortisol has been detected (Preisler et al., 2000). 
However, cortisol may interfere with the number and efficient function of PMN (Hopster et al., 
1998; Kulberg et al., 2002). In milk, cortisol increases at the time of parturition, but falls back to 
preparturition levels one day post-partum; in blood, no changes occur in cortisol levels (Schwalm 
and Tucker, 1978; Preisler et al., 2000).  
 
During the post-partum period the diapedesis of PMN into the infected quarters (Hill et al., 1979; 
Hill, 1981) and phagocytosis (Kehrli et al., 1989; Hoeben et al., 2000b; Mehrzad et al., 2001b) are 
impaired compared with later lactation. PMN functions may be altered due to hyperketonaemia 
(Suriyasathaporn et al., 2000; Zerbe et al., 2000), which is commonly seen during early lactation 
(Jorritsma et al., 2001). Severe signs in experimentally induced E. coli mastitis were not associated 
with a mild negative energy balance, as indicated by elevated levels of non-esterified fatty acids or 
β-OH-butyrate (Kornalijnslijper et al., 2003), but an association was found with ketonaemia 
(Kremer et al., 1993).  
 
The more severe response seen in early lactation may also be caused by a higher production of 
TNFα by mononuclear cells during this period (Sordillo et al., 1995). In endotoxin mastitis, TNFα 
was detected in plasma and milk of early-lactating cows (Blum et al., 2000; Hoeben et al., 2000a) 
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but not in mid-lactating cows (Shuster et al., 1993). However, in the last-mentioned study, the 
amount of endotoxin used for the induction of mastitis was much lower.  
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6. AIMS OF THE STUDY 
 
 
Factors affecting the severity and outcome of E. coli mastitis in dairy cows were investigated in the 
thesis. These included both bacterial and cow factors. Specific objectives were as follows: 
 
1. To characterize the virulence factors present in E. coli isolates from bovine mastitis. 
 
2. To determine the antimicrobial susceptibility of E. coli isolates from bovine mastitis. 
 
3. To investigate associations between both virulence factors and antimicrobial 
 resistance of isolates and the clinical course and outcome of E. coli mastitis.  
 
4. To investigate differences in response of early- and late-lactating dairy cows in the 
 experimental E. coli endotoxin mastitis model. 
 
5. To investigate the roles of TNFα and SAA in experimental E. coli endotoxin mastitis 
 in early- and late-lactating dairy cows. 
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7. MATERIALS AND METHODS 
 
 
This thesis comprises two main studies: a study of clinical mastitis caused by E. coli in Finland and 
Israel, and a study of experimental endotoxin mastitis. 
 
 
7.1. FIELD DATA (I, II, III) 
7.1.1. Escherichia coli isolates  
A total of 273 Escherichia coli isolates (160 from Finland and 113 from Israel) from acute clinical 
cases of bovine mastitis were investigated. In Finland, the isolates were collected during 1990-1996 
(16-34 isolates per year). In Israel, the isolates were collected during the years 1996-1997, 21 
isolates in 1996 and 79 isolates in 1997. All isolates were studied for virulence factors (I), and 100 
isolates from both Finland and Israel were randomly chosen for antimicrobial susceptibility testing 
(II). From the Finnish isolates, 155 were used to study the associations between virulence factors 
and clinical signs (III); the five excluded isolates were missing background information.  
 
Milk samples were taken during routine farm calls by the attending veterinarian from the affected 
quarter of each cow using an aseptic technique. For bacterial isolation, 0.01 ml of milk was cultured 
as described by the National Mastitis Council (NMC, 1999). From the Finnish milk samples, the 
milk N-acetyl-β-D-glucosaminidase (NAGase) activity was determined. After 3 to 4 weeks, follow-
up samples were taken from the Finnish cows for bacterial and milk NAGase analyses; 26 cases 
missed the resampling.  
 
 
7.1.2. Conventional bacteriology 
Isolates were preliminarily identified as Escherichia coli by phenotypic methods: colony 
morphology on a blood agar, Gram stain and growth on an EMB agar (NMC, 1999). The diagnosis 
was later confirmed using the API 20E test (bioMérieux, Marcy l’Etoile, France) (NCCLS, 1999). 
The isolates were stored in a semi-solid broth (Lab Lemco Broth, Oxoid, Hampshire, UK) at room 
temperature.  
 
 
7.1.3. Isolate classification 
From the Finnish material, clinical signs and changes in milk appearance were recorded at the time 
of sampling. Cases of mastitis were classified as mild or severe and persistent or non-persistent. In 
mild mastitis, cows had no or slight fever and only moderate changes in the udder and milk. In 
severe mastitis, cows were depressed, had high fever, no appetite, a swollen and painful udder and 
substantial changes in milk appearance. The intramammary infection was classified as persistent if 
the follow-up sample harboured E. coli growth. The cows were also divided into three groups 
according to lactation stage: 0-21, 22-210 and over 211 days post-partum (PP).  
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7.2. EXPERIMENTAL ENDOTOXIN MASTITIS (IV, V) 
7.2.1. Animals 
Experimental endotoxin mastitis was induced in 10 Finnish Ayrshire dairy cows. Two cows were 
primiparous and eight multiparous (2nd - 4th lactation). All cows were clinically healthy, free from 
mastitis pathogens and had a low milk SCC (<150 000/ml). Cows were housed in a stanchion barn 
and fed good quality silage and hay freely. Concentrate was given twice daily. They were milked 
twice a day, at 7:00 and 17:00.  
 
 
7.2.2. Experimental design 
Cows were challenged twice using a cross-over design; in the early lactation (EL) period, 6 to 15 
days after parturition, and in the late lactation (LL) period, 137 to 77 days before the next 
parturition. The daily milk yield was 17 to 38 kg in EL, and 5 to 19 kg in LL cows. Cows were 
randomly allocated into two subgroups; one group was challenged first in the EL period and the 
other group first in the LL period. The endotoxin challenge was done after the morning milking into 
one hind-quarter with 100 µg of Escherichia coli 0111:B4 lipopolysaccharide B (Bacto©, Difco 
Laboratories, INC., Detroit, USA) diluted in 5 ml of sterile isotonic NaCl. The same quarter was 
used at both challenges. The contralateral quarter served as a control. During the endotoxin 
experiment the cows received no treatments. One cow was excluded since it did not conceive. The 
Ethics Committee of the Faculty of Veterinary Medicine, University of Helsinki, approved the 
study protocol. 
 
Milk samples were collected from the challenged and control quarters of each cow at 0, 2, 4, 8, 12, 
24, 32, 48 and 72 h. Blood samples were collected from the jugular vein into EDTA and serum 
tubes at the same time-points as the milk samples. Milk samples were stored frozen at -21ºC and 
serum samples at -70ºC.  
 
 
7.2.3. Clinical scoring 
Systemic and local signs were recorded throughout the experiment. Systemic signs included general 
attitude, heart rate, rectal temperature and appetite; local signs included swelling, heat, and pain in 
the udder. Appearance of milk in the challenged quarter was also recorded. Systemic and local signs 
and milk appearance were scored from 1 to 3, with half numbers also used. In this scoring system, 1 
was defined as a normal and 3 as a severe reaction, the latter indicated rectal temperature >40.5˚C, 
anorexia and depression, severe swelling and pain in the udder and serous or pus-like milk (Pyörälä 
et al., 1994). The response parameter was formed by calculating the average of these scores. This 
parameter was handled as a continuous parameter and it fit the normal distribution curve well.  
Severity of response was assessed as follows: <2 was classified as a mild, ≥2 but <3 as a moderate 
and 3 as a severe response. Total milk yield was recorded for each cow at both milking times and 
the 24-h milk yield was calculated. 
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7.3. METHODS OF ANALYSIS 
7.3.1. Virulence factors (I, III) 
7.3.1.1. Control strains 
Several control strains were used for the detection of different virulence factors by polymerase 
chain reaction (PCR). E. coli 25KH9 was used as a positive control for the detection of F17a, E. 
coli S5 for F17b and CNF2, E. coli CS31A for F17c and surface antigen 31A, E. coli 111KH86 for 
F17d, E. coli BM2-1 for S fimbriae and CNF1, E. coli IH87131 for aerobactin and P fimbriae, E. 
coli 262KH89 (provided by Pasteur Institute, France) for Afa7D and Afa7E, E. coli 239KH89 
(provided by Pasteur Institute, France) for Afa8D and Afa8E, and Salmonella typhimurium 2696 for 
TraT. E. coli strain A56 was the positive control for bacteriophage K1, and E. coli strain IHE11038 
for bacteriophage K5. In the analysis of serum resistance, E. coli FT240 was used as a control for 
sensitive strains, and E. coli FT64 for resistant strains (Fang and Pyörälä, 1996).  
 
All strains had been stored either in semi-solid nutrient broth (Lab Lemco Broth, Oxoid, 
Hampshire, UK) at 20°C or in frozen serum-meat broth with 10% glycerol at -70°C. Strains were 
refreshed by culturing them on trypticase-soy agar (TSA) for 24 h at 37°C.   
 
 
7.3.1.2. Polymerase chain reaction 
PCR was used to analyse the genes of F17-related fimbriae, P fimbriae, S fimbriae, CNF1, CNF2, 
aerobactin, E. coli surface antigen CS31A, afimbrial adhesins of the Afa family and TraT. Analyses 
were carried out in three multiplex PCRs (MXP) (Table 2); MXP1 was used to detect the genes for 
F17a and F17d major subunits and subfamily I adhesin, MXP2 for F17b and F17c major fimbrial 
subunits and subfamily II adhesin (Bertin et al., 1996), and PAP for P and S fimbriae, CNF1 and 
aerobactin (Yamamoto et al., 1995). Seven PCR reactions were done individually: clp (Bertin et al., 
1998), afa7D, afa7E, afa8D, afa8E (Lalioui et al., 1999), CNF2 and TraT, the last two of which are 
described in more detail in study I.  
 
All PCRs were performed in a total volume of 50 µl, except for the TraT PCR, which was carried 
out in 25 µl. For the template, 10 µl of fresh bacterial mass from the agar plate was suspended in 
500 µl of sterile MilliQ H2O. One unit of DyNAzyme DNA polymerase (Finnzymes, Espoo, 
Finland) was used for each PCR, except for the 0.5 U used in the clp PCR. Optimized DyNAzyme 
buffer (Finnzymes, Espoo, Finland) was used as a buffer. Multiplex PCRs MXP1 and MXP2 
contained 0.6 µM (30 pmol/50 µl) of each primer, 100 µM of each deoxynucleoside triphosphate 
(Finnzymes, Espoo, Finland) and 2 µl of the template. The PCRs for CNF2 and Afa were as above, 
except for the concentration of the primers, which were 0.3 µM and 0.45 µM, respectively. The 
PAP PCR contained 0.4 µM of each primer, 100 µM of each dNTP, 1.25 mM of Mg2 and 5 µl of 
template. The clp PCR contained 0.3 µM of each primer, 100 µM of each dNTP and 3 µl of 
template. 
 
Six different amplification procedures were used in the UnoII Thermoblock thermal cycler 
(Biometra, Göttingen, Germany). The parameters were denaturation for 2 min at 95°C and 1 min at 
94°C, annealing for 1 min at 55°C for MXP1, TraT and clp, 59°C for MXP2, 52°C for CNF2, 63°C 
for PAP, 60°C for afa7D, afa8D and afa8E, and 47°C for afa7E, extension for 1 min at 72°C and 
final extension for 5 min at 72°C. The cycle was repeated 25 times. Nine microliters of the PCR  
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Table 2. PCR reactions used for the detection of virulence factors. 
 
PCR Primer Primer sequence 
Product 
size Reference strain¤ Virulence factor 
      
MXP1 P2 CTGATAAGCGATGGTGTAATTAAC1    
 P3 GCTGGAAGGGTGCAATACGCCTG1 321 bp 25KH9 F17a-A 
 P6 GATAGTTCATAACCTTAATATTGCA1 239 bp 111KH86 F17d-A 
 P7 CGGAGCTAATACTGCATCAACC1 615 bp  Subfamily I adhesins 
(F17a-G, F111) 
 P9 TGTTGATATTCCGTTAACCGTAC1    
      
MXP2 P2 CTGATAAGCGATGGTGTAATTAAC1    
 P4 CAACTAACGGGATGTACAGTTTC1 323  bp S5 F17b-A 
 P5 GCAGGAACCGCTCCCTTGGC1 416 bp CS31A F17c-A 
 P8 CGTGGGAAATTATCTATCAACG1 615 bp  Subfamily II adhesins 
(F17b-C, F17c-G) 
 P9 TGTTGATATTCCGTTAACCGTAC1    
      
PAP Pap1 GCAACAGCAACGCTGGTTGCATCAT4    
 Pap2 AGAGAGAGCCACTCTTATACGGACA4 336 bp IH87131 P fimbriae 
 Sfa1 CTCCGGAGAACTGGGTGCATCTTAC4    
 Sfa2 CGGAGGAGTAATTACAAACCTGGCA4 410 bp BM 2-1 S fimbriae 
 Aer1 TACCGGATTGTCATATGCAGACCGT4    
 Aer2 AATATCTTCCTCCAGTCCGGAGAAG4 602 bp IH87131 Aerobactin 
 CNFI AAGATGGAGTTTCCTATGCAGGAG4    
 CNFII CATTCAGAGTCCTGCCCTCATTATT4 498 bp BM 2-1 CNF1 
      
CNF2 CNF1 ACTGAAGAAGAAGCGTGGAATA2    
 CNF2 ATAAGTTGAGCCGAGCGAGG2 654 bp S5 CNF2 
      
TRAT TraTF GATGGCTGAACCGTGGTTATG2  S. Typhimurium 
2696 
 
 TraTR CACACGGGTCTGGTATTTATGC2 307 bp  TraT 
      
clp clpG1 GGGCGCTCTCTCCTTCAAC3    
 clpG2 CGCCCTAATTGCTGGCGAC3 385 bp 31A CS31A 
      
AFA7D Afa7D1 GCAGAGCTGAGTCTTGATGTCCGT6    
 Afa7D2 CGTAATTATTCCTGTGAACGGCTGTCCA6 377 bp AFA7 Afa7D 
      
AFA7E Afa7E1 GCTAAATCAACTGTTGATGTT6    
 Afa7E2 GGACAATCCAAATGGCGAATTA6 618 bp AFA7 Afa7E 
      
AFA8D Afa8D1 GTTGAACTGAGTTCTTAATACCAGTG6    
 Afa8D2 TGAGCATTCTCCGCTAACTGATAAT6 354 bp AFA8 Afa8D 
      
AFA8E Afa8E1 CTAACTTGCCATGCTGTGACAGTA6    
 Afa8E2 TTATCCCCTGCGTAGTTGTGAATC6 302 bp AFA8 Afa8E 
1 Bertin et al., 1996 
2 This study 
3 Bertin et al., 1998 
4 Yamamoto et al., 1995 
6 Lalioui et al., 1999 
¤Strains of E. coli if not otherwise stated 
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product was analysed by agarose gel electrophoresis (140 V, 1 h) in a 1.5% agarose gel containing 
ethidium bromide. The PCR product was visualized with UV light. 
 
7.3.1.3. Capsule formation 
Capsule formation of the strains was examined by using K1 and K5 bacteriophages. Bacteriophages 
were stored at -70°C as phage lysates. Phage stocks were prepared with the method described by 
Mäkelä (1985), using E. coli A56 (K1) and E. coli IHE11038 (K5) as propagating strains. 
 
The isolates and control strains were spread on TSA plates. One drop of 10-3 and 10-2 diluted K1 
and K5 bacteriophage lysates, respectively, was pipetted onto the agar. Plates were air-dried and 
incubated at 37°C for 24 h. The isolates lysed by capsule-specific phages were regarded as positive 
for K1 or K5. 
 
 
7.3.1.4. Serum resistance 
Serum resistance was analysed by a turbidometric assay using microtitre plates (Pelkonen and 
Finne, 1987). Blood for the serum was collected from 14 healthy young cows at a slaughter. Blood 
was pooled and allowed to clot at room temperature before separation of normal bovine serum (N-
BS). Inactivated bovine serum (I-BS) and bovine serum with inactivated classical complement 
pathway (EGTA-BS) were prepared and stored as described earlier (Pelkonen and Finne, 1987). 
 
The bacterial suspensions were mixed with bovine serum to yield a final serum concentration of 
75% and incubated at 37°C for 3 h. The sensitivity to N-BS and EGTA-BS was measured in 
duplicate. Inactivated serum I-BS was used as a control. 
 
For the turbidimetric assay (Pelkonen and Finne, 1987), 150 µl of serum (N-BS, EGTA-BS or I-BS) 
was mixed with 50 µl of bacterial suspension. The mixture contained approximately 2 x 108 cfu/200 
µl. Variation of the concentration between 104 and 1010 bacterial cells/ml had no effect on serum 
resistance (Olling, 1977). The first well of the microtitre plate (Titertek, 350 µl, 96 flat-bottom well) 
served as a blank control, containing 150 µl of N-BS serum and 50 µl of 0.9% NaCl. The 
absorbance at 620 nm (Labsystems Multiskan MCC/340) was measured at 0, 60, 120 and 180 min. 
The suspensions were gently mixed with a pipette before every measurement. The initial 
absorbance values at time zero varied between 0.1 and 0.4. The change in absorbance was 
calculated as a percentage (remaining absorbance divided by initial absorbance).   
 
 
7.3.2. Antimicrobial susceptibility testing (II) 
7.3.2.1. Control strains 
For the detection of minimal inhibition concentration (MIC) E. coli ATCC 25922, Enterococcus 
faecalis ATCC 29212 and Staphylococcus aureus ATCC 29213 (NCCLS, 1999) were used as 
reference strains.  
All strains had been stored either in semi-solid nutrient broth (Lab Lemco Broth, Oxoid, 
Hampshire, UK) at 20°C or in frozen serum-meat broth with 10% glycerol at -70°C. Strains were 
refreshed by culturing them on TSA for 24 h at 37°C.   
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7.3.2.2. Antimicrobial agents  
MIC values of the isolates were analysed for eight different antimicrobials: ampicillin (ampicillin 
sodium salt, Sigma Chemical Co., St. Louis, MO, USA, lot 127HO285), cephalexin (cefalexin 
hydrate, Sigma, lot 24H0420), ceftazidime (ceftazidime pentahydrate, Sigma, lot 35H0473), 
dihydrostreptomycin (DHS) (dihydrostreptomycin sesquisulfate salt, Sigma, lot 66H04142), 
gentamicin (gentamicin sulfate, Sigma, lot 27H0744), tetracycline (tetracycline, Sigma, lot 
38H1324), trimethoprim-sulphadiazine (TS) (trimethoprim, Sigma, lot 105H0136; sulfadiatsin, 
Sigma, lot 96H1175) and ciprofloxacin (ciprofloxacin*HCL, Bayer Ag, Levekusen, Germany, lot 
303477A)  by an agar dilution method (NCCLS, 1999). The antimicrobial agent stock solutions 
were prepared and diluted as recommended by their respective manufacturers in a NaCl solution to 
a concentration of 1280 µg/ml. TS was made up to a ratio of 1:5, so the actual concentrations of 
these compounds in stock solution were 213.33 µg/ml for trimethoprim and 1066.66 µg/ml for 
sulphadiazine. 
 
The final concentrations ranged in the two-step dilutions from 128 µg/ml to 0.5 µg/ml for 
ampicillin, cephalexin, DHS, tetracycline and TS, from 64 µg/ml to 0.25 µg/ml for gentamicin and 
from 16 µg/ml to 0.0625 µg/ml for ciprofloxacin and ceftazidime, which also had a concentration of 
32 µg/ml.  
 
 
7.3.2.3. Minimal inhibition concentration 
The test isolates and reference strains were prepared in a suspension at a concentration of 107 cfu/ml 
(NCCLS, 1999). Antimicrobial agars were inoculated with the respective bacterial solutions using 
an Automatic Multipoint Inoculator (Mast Diagnostics LTD., Merseyside, UK) according to 
NCCLS recommendations. Growth of the inoculates was determined after incubation at 37°C for 20 
h by observing the agar plates from directly above. The MIC value recorded was the lowest 
concentration of the antibiotic to inhibit growth of the inoculated bacteria (NCCLS, 1999). 
 
The MIC breakpoint values for in vitro susceptibility were 8 µg/ml for ampicillin, cephalexin, DHS 
and TS, 4 µg/ml for gentamicin and tetracycline (NCCLS, 1999), 0.5 µg/ml for ceftazidime and 
0.25 µg/ml for ciprofloxacin. The isolate was considered resistant to a certain antimicrobial when 
the MIC value was higher than the MIC breakpoint value of that antimicrobial. MIC values for 50% 
and 90% of isolates tested (MIC90 and MIC50) were calculated for all antimicrobials tested. 
 
 
7.3.3. Milk inflammation parameters 
7.3.3.1. Somatic cell count (IV) 
Milk SCC was measured with a Fossomatic instrument (Foss Electric, Hillerød, Denmark); for 
samples with clots and flakes, a Coulter Counter particle counter (Coulter Electronics Ltd., 
Northwell, England) was used (IDF, 1991). SCC values were measured with the Coulter Counter at 
4, 8 and 24 h, and at other times with the Fossomatic. Values over 15x106/ml were recorded as 
15x106/ml.  
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7.3.3.2. N-acetyl-β-D-glucosaminidase (III, IV) 
Milk NAGase activity was measured using a commercial Milk NAGase kit (Applied Diagnostics 
Corporation, Helsinki, Finland) (Mattila and Sandholm, 1986).  
 
 
7.3.4. Haematological parameters (IV, V) 
Haematological parameters (packed cell volume (PCV), haemoglobin, total and differential 
leucocyte count) were determined within 2 h of sampling using an automated multiparameter 
analyser with software for animal samples (CELL-DYN 3700 System, ABBOTT Diagnostic 
Division, ABBOTT Park, IL, USA).   
 
 
7.3.5. Serum biochemical parameters (IV) 
Serum cortisol levels were measured by radioimmunoassay (Coat-A-Count Cortisol, Diagnostic 
Product Corporation, Helsinki, Finland). Serum urea and creatinine were measured with an 
enzymatic kinetic method (Fabiny and Ertigshausen, 1971; Gutmann and Bergmeyer, 1974) using 
an automated analyser (KONE Pro, ThermoClinical Labsystems, Espoo, Finland). Another 
automated analyser (KONE Specific, ThermoClinical Labsystems, Espoo, Finland) was used to 
determine serum aspartate aminotransferase (ASAT) activity (Scandinavian Society for Clinical 
Chemistry and Clinical Physiology, 1974) and free fatty acids (FFA) concentration (Waco 
Chemicals GmbH, Neuss, Germany). The KONE Lab-Microlyte 3+2 (ThermoClinical Labsystems, 
Espoo, Finland) analyser was used to determine serum Ca2+.  
 
 
7.3.6. Neutrophil function (IV) 
PMN phagocytosis and respiratory burst in blood and milk were determined by zymosan-induced 
CL as described earlier (Lilius and Waris, 1984; Lojek et al., 1997). Briefly, 20 µl of luminol (10 
mM), 25 µl of opsonized zymosan (20 mg/ml), 180 µl of HBSS (0.1% gelatin) and 25 µl of EDTA 
blood (1:200 dilution) or milk (1:1000 dilution) were pipetted into the wells of a microtitre plate, 
and the CL was measured at 37°C for 40 min with a luminometer (Luminoskan, Labsystems, 
Helsinki, Finland). The samples were analysed in triplicate within 2 h of sampling. The highest CL 
value during the 40-min measuring time was considered to be the CL value of that time-point. The 
value was divided by the number of PMN in blood or the number of somatic cells in milk at that 
time to obtain the CL of one cell.  
 
 
7.3.7. Tumour necrosis factor alpha (V) 
The enzyme-linked immunosorbent assay (ELISA) used in this study was modified from Ellis et al. 
(1993) by Røntved et al. (unpublished results).  
 
The following adjustments were made for the quantification of TNFα in serum. Serum samples 
were diluted 1:2 in  tris-buffered saline (TBS: 0.05 M Tris, 0.15 M NaCl, pH 7.6) containing 0.05% 
tween and 0.5% gelatin (Sigma-Aldrich Co., St. Louis, USA) (TBS-T-g), and duplicates of the 
samples were added to two coated plates and incubated overnight at 4°C. A 2-fold dilution of 
recombinant bovine TNFα (Ciba-Geigy, Basel, Switzerland) in 50% TBS-T-g and 50% FCS was 
used as the standard, starting at 62.5 ng/ml. A high and a low positive control were added in a ratio 
of 1:2. A mixture of 50% TBS-T-g and 50% FCS was used as a negative control.  
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The same ELISA was slightly modified to analyse TNFα in milk samples. Before TNFα analysis, 
milk samples were centrifuged at 25.000 g for 40 min at 4°C. Fat was removed and the supernatant 
collected; the supernatant was then centrifuged again at 2000 g for 20 min at 4°C to remove any 
remaining fat. The positive and negative controls for milk samples were treated in a similar way. 
The milk supernatants were diluted from 1:4 to 1:512 (2-fold dilution) in TBS-T-g to find the most 
appropriate dilution. The diluted samples were tested in triplicate. The samples were then added to 
coated plates and incubated overnight at 4°C. A 2-fold dilution of recombinant bovine TNFα in 
TBS-T-g with 6.25% milk supernatant was used as a standard, starting at 62.5 ng/ml (the bo rTNFα 
stock was 3.125 µg/ml and kept in TBT-g with 10% heparin stabilized bovine plasma). A high 
positive control was added in dilutions of 1:64 and 1:128, and a low positive control in a dilution of 
1:8; TBS-T-g with 6.25% milk supernatant was used as a negative control. The following day, the 
procedure was continued as described above.  
 
The interassay (between days) and intraplate coefficients of variation for the serum TNFα ELISA 
were below 14.4% and 14.8%, respectively, and for the milk TNFα ELISA as follows: for the low 
control (5.8 ng/ml diluted 1:8) 9.8% and 6.7%, and for the high control (59.5 ng/ml diluted 1:64) 
6.6% and 9.1%, respectively. The detection limit of the ELISA was 0.5 ng/ml for the serum and 
around 1.0 ng/ml for the milk.  
 
 
7.3.8. Serum amyloid A (V) 
The concentration of SAA in serum and milk was determined by using a commercial ELISA kit 
(Tridelta Development, Wicklow, Ireland) and as described by Eckersall et al. (2001). For high 
SAA concentrations, the samples were diluted if necessary. The detection level of SAA was >0.3 
µg/ml for both serum and milk samples, and the upper limit for the analysis was <750 µg/ml. The 
inter-assay and intra-assay coefficients of variation for SAA analysis were <10 % and < 5 %. 
 
 
7.4. STATISTICS 
Pearson’s chi-square test was used to study differences in the frequencies of resistance to the 
antimicrobials tested among the isolates (II) and in the association of F17-related fimbriae, P and S 
fimbriae (grouped together), CNF1 and CNF2, aerobactin, TraT, serum resistance and the clinical 
course of mastitis with the lactation stage (III). Multiple comparisons were carried out between 
different factors and their combinations. 
 
Fisher’s exact test was used to examine the association of F17-related fimbriae, P and S fimbriae 
(grouped together), CNF1 and CNF2, aerobactin, TraT and serum resistance with the clinical course 
of mastitis (III). 
 
Analysis of variance was used to study the association of F17-related fimbriae, P and S fimbriae 
(grouped together), CNF1 and CNF2, aerobactin, TraT, serum resistance and the clinical course of 
mastitis with milk NAGase activity (III). 
 
Repeated measures analysis of variance was used to test the effect of lactation stage on systemic 
signs, local signs, milk appearance, rectal temperature, TNFα in milk and SAA in serum and in 
milk. Significance of hour and stage*hour effect were evaluated by Greenhouse-Geisser adjusted P 
values (V).  
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A mixed linear model (Lindsay, 1993) with two different models were used to test the effect of 
lactation stage on logNAGase, logSCC, WBC, leucocyte count, neutrophil count, PCV, 
haemoglobin, CL in milk and in serum, urea, creatinine, cortisol, FFA, ASAT and  Ca2+. All 
estimates were calculated using the MIXED procedure in SAS statistical software (SAS 2002, SAS 
Institute Inc., Gary, NC, USA) (IV). 
 
In all statistical analyses, a P value of <0.05 was considered significant. 
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8. RESULTS 
 
 
8.1. FIELD DATA  
8.1.1. Characteristics of mastitis (III) 
Of the 155 Finnish clinical mastitis cases caused by E. coli, 77 were categorized as mild and 78 as 
severe. Sixteen cows had persistent E. coli mastitis, 116 had non-persistent mastitis and 26 missed 
the resampling. Severity of the acute stage in persistent and non-persistent mastitis did not differ 
significantly. Milk NAGase activity was significantly (P<0.01) lower in severe than in mild mastitis 
(221 + 23 arbitrary units (AU) vs. 291 + 21 AU). Thirty-two per cent of clinical cases of mastitis 
occurred in EL (0-21 days PP), 54% in mid-lactation (21-210 days PP) and 14% in LL (over 211 
days PP). Lactation stage was significantly (P<0.05) associated with severity: clinical signs tended 
to be milder EL than in LL (Figure 2). Lactation stage did not affect the persistence of mastitis or 
the presence of any virulence factors.  
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Figure 2. Distribution of cows with mild (dashed bar) and severe (open bar) course of E. coli mastitis 
according to lactation stage. The number of cows in early lactation (0-21 days post-partum) was 50, in mid-
lactation (22-210 days post-partum) 83 and in late lactation (over 211 days post-partum) 22. 
 
 
8.1.2. Virulence factors of E. coli isolates (I) 
Of the 160 Finnish and 113 Israeli E. coli isolates, 79 (49%) and 48 (42%), respectively, had at least 
one virulence gene detected by PCR. The most common gene in both Finnish and Israeli isolates 
was traT (Table 3). It was detected alone in 52% of Finnish and 88% of Israeli isolates positive for 
any virulence gene. Other genes were rare in Israeli isolates (Table 3). None of the isolates 
contained genes for F17a, Afa7D, Afa7E and CS31A .  
 
Most of the virulence genes were detected in different combinations. The combinations varied 
markedly and each combination was typically present in only a few isolates. Two major groups of 
combinations were detected; those with F17-related genes and those with genes for S and P 
fimbriae and CNF1 (Table 4). The genes for CNF2, aerobactin and TraT were found in both 
groups.  
 
 
days post-partum 
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Table 3. Prevalence of virulence factors among E. coli isolated from mastitis. 
 
Virulence Finnish  Israeli 
isolates 
(n=160) 
 isolates 
(n= 113) 
factor 
n %  n % 
      
F17a 0 0  0 0 
F17b 1 0.6  1 0.9 
F17II 5 3.1  0 0 
F17c 4 2.5  0 0 
F17d 5 3.1  0 0 
S fimbria 12 7.5  1 0.9 
P fimbria 11 6.9  0 0 
CS31A 0 0  0 0 
Afa7D 0 0  0 0 
Afa7E 0 0  0 0 
Afa8D 2 1.3  0 0 
Afa8E 2 1.3  0 0 
CNF2 23 14.4  4 3.5 
CNF1 12 7.5  1 0.9 
aerobactin 18 11.3  5 4.4 
TraT 59 36.9  46 40.7 
Negative 81 51.0  65 58.0 
 
 
Table 4.  Different combinations of virulence genes detected among Finnish and Israeli E. coli isolates. 
 
Combinations of genes Finnish isolates Israeli isolates 
   
F17 3 0 
F17, traT 1 0 
F17, afa8DE 1 0 
F17, cnf2, aer 1 0 
F17, cnf2, traT 2 0 
F17, cnf2, aer, traT 4 1 
F17, cnf2, afa8DE, aer 1 0 
F17, cnf2 1 0 
SP, cnf2, cnf1, aer, traT 1 1 
SP, cnf2, cnf1, aer 1 0 
SP, cnf2, cnf1  6 0 
SP, cnf1 4 0 
cnf2, aer,  traT 4 1 
cnf2 2 1 
aer, traT 6 2 
traT 41 42 
Negative 81 65 
Total number 160 113 
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E. coli isolates were divided into the following four groups according to their growth in 75% bovine 
serum: resistant, intermediate, slow-intermediate and sensitive. Resistant isolates continued growth 
throughout the incubation period. Intermediate isolates also continued growing but more slowly 
than resistant strains. Slow-intermediate isolates grew rapidly for the first 60 min but then showed 
lysis. Sensitive isolates grew only weakly and after 60 min showed clear lysis. Only 6% of the 
Finnish isolates were defined as serum-sensitive, 7% were slow-intermediate, 29% were 
intermediate and 59% were clearly resistant to serum. Among the Israeli isolates, 31% were 
sensitive, 15% slow-intermediate, 30% intermediate and 17% clearly resistant. The Finnish strains 
overall were more resistant to serum than the Israeli strains. Strains classified as resistant or 
intermediate had more genes for virulence factors than strains classified as sensitive, slow-
intermediate or sensitive to I-BS. This trend was the same in both Finnish and Israeli strains (Table 
4). For all groups, similar growth curves were observed in N-BS and EGTA-BS. Eight Israeli 
isolates were sensitive to I-BS and could not be analysed further. 
 
All isolates lacked K1 and K5 capsules.  
 
 
8.1.3. Antimicrobial resistance (II) 
The MIC values of E. coli isolates from both Finland and Israel were quite similar and relatively 
low (Table 5). The majority of the isolates were susceptible to the antimicrobial agents studied. A 
total of 30% of Finnish and 24% of Israeli isolates were resistant to one or more antimicrobials. No 
gentamicin-, ciprofloxacin- or ceftazidime-resistant isolates were detected. The only significant 
(P<0.01) difference in the number of resistant isolates between the two countries was for 
cephalexin; 16% of Finnish isolates but only 3% of Israeli isolates were resistant to this first-
generation cephalosporin. For the other antimicrobial agents, the proportions of resistant strains 
were higher for Israeli isolates than for Finnish ones, although the differences were not significant 
(Table 5). 
 
While MIC50 values for Finnish and Israeli isolates did not differ markedly, differences were seen 
between MIC90 values (Table 5). For cephalexin, the Finnish isolates had one dilution higher MIC90 
values than Israeli isolates, whereas for ceftazidime and TS the MIC90 values were one dilution 
higher among Israeli than among Finnish isolates. For DHS and tetracycline, Israeli isolates had 
clearly higher MIC90 values than Finnish isolates. 
 
Thirty-two isolates, 20 from Finland and 12 from Israel, were resistant to only one antimicrobial, 
whereas 22 isolates, 10 Finnish and 12 Israeli, were resistant to two or more antibiotics (Table 6). 
Of the total amount of resistant isolates, 41% were multiresistant. They formed 10 different 
combinations; tetracycline was included in all except one combination (Table 6). 
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Table 5. Number of resistant isolates, MIC501 and MIC90 2 values of the tested E. coli isolates from Finland and Israel (n=100 isolates/country). 
 
No of resistant isolates  MIC50  (µg/ml) MIC90 (µg/ml) 
Antimicrobials 
MIC3 break-
point values 
(µg/ml) 
Range of the MIC 
values (µg/ml) Finnish Israeli  Finnish Israeli Finnish Israeli 
Ampicillin 84 1- >128 7 10  4 4 8 8 
Cephalexin 8 4 2- >128 16* 3  8 8 16 8 
Ceftazidime 0.5 <0.0625- 1 0 0  0.125 0.25 0.25 0.5 
DHS5 8 4 <0.5- >128 9 13  4 2 8 32 
Gentamicin 4 4 <0.25- 4 0 0  1 0.5 1 1 
Tetracycline 4 4 1- >128 14 15  4 2 8 64 
TS6 8 4 <0.5- >128 2 4  0.25 2 2 4 
Ciprofloxacin 0.25 <0.0625- 0.125 0 0  <0.0625 <0.0625 <0.0625 <0.0625 
 
1 Minimal inhibition concentration for 50% of isolates tested 
2 Minimal inhibition concentration for 90% of isolates tested 
3 Minimal inhibition concentration  
4 According to the NCCLS (1999) 
5 Dihydrostreptomycin 
6 Trimethoprim-sulfadiazine 
* Significant (p<0.01) difference between countries 
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Table 6. Resistance patterns among E. coli strains isolated from bovine mastitis in Finland and Israel. 
 
Number of isolates 
Resistance pattern Finnish Israeli 
       
Tetracycline DHS1 Ampicillin Cephalexin TS2 1 0 
Tetracycline DHS Ampicillin Cephalexin 1 0 
Tetracycline DHS Ampicillin TS 0 4 
Tetracycline DHS Ampicillin 0 1 
Tetracycline DHS Cephalexin 1 0 
Tetracycline DHS TS 1 0 
Tetracycline DHS 1 4 
Tetracycline Ampicillin Cephalexin 1 0 
Tetracycline Ampicillin 2 1 
DHS Ampicillin 2 2 
Tetracycline  6 5 
DHS  2 2 
Ampicillin  0 2 
Cephalexin  12 3 
Negative  70 76 
Total  100 100 
1 dihydrostreptomycin 
2 trimethoprim-sulfadiazine 
 
 
8.1.4. Association of virulence factors and antimicrobial resistance with clinical characteristics 
and outcome of mastitis (III) 
Neither virulence factors nor antimicrobial resistance was significantly associated with the severity 
of mastitis (Figure 3). Isolates positive for S and P fimbriae (P<0.001), CNF1 (P<0.001) and CNF2 
(P<0.05) were significantly associated with persistent mastitis (Figure 4). NAGase activity of milk 
in cases with E. coli isolates positive for S and P fimbriae and CNF1 was on average 389 ± 47.6 
AU, which was significantly (P<0.01) higher than with isolates negative for these virulence factors, 
average activity being 245 ± 14.5 AU. In F17-positive isolates, NAGase activity was significantly 
(P<0.01) lower as compared with the cases caused by bacteria without these virulence factors (146 
± 33.8  AU and 268 ± 17.0 AU). 
 
Some virulence factors were associated with certain antimicrobial resistance patterns. A significant 
association were present between tetracycline resistance and possession of virulence gene cnf1, 
cnf2, SP, aer (P<0.01) or traT (P<0.05). These virulence genes were often found in the same 
isolates (Table 4). A significant (P<0.05) association was also observed between DHS resistance 
and possession of F17, cnf2 or aer virulence genes, and between ampicillin resistance and the gene 
for aerobactin. 
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Figure 3. Proportion of E. coli isolates (n=155) causing mild (dashed bar) or severe (open bar) course of 
mastitis in relation to certain virulence factors or antimicrobial resistance; Virgr= positive for any virulence 
factor, Abgr=resistant to any antimicrobial agent, SR= serum resistant, F17= positive for F17 fimbriae, SP= 
positive to S or P fimbriae, CNF1= positive for CNF1, CNF2= positive for CNF2, AER= positive for 
aerobactin, TraT= positive for TraT, TET= resistant to tetracycline, DHS= resistant to DHS, AMP=resistant 
to ampicillin, KEF= resistant to cephalexin.  
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*P<0.05 
***P<0.001 
 
Figure 4. Proportion of E. coli isolates (n=155) causing non-persistent (dashed bar) or persistent (open bar) 
course of mastitis in relation to certain virulence factors or antimicrobial resistance. A significant difference 
is indicated with an asterisk. Legends as in Figure 3. 
 
 
8.2. EXPERIMENTAL ENDOTOXIN MASTITIS 
8.2.1. Mastitis outcome (IV) 
In experimental endotoxin mastitis, all cows developed clinical signs at both challenges, although 
none of the cows had a severe response. Clinical response, including systemic and local signs and 
milk appearance, was more severe in EL than in LL. Systemic signs peaked between 4 and 8 h PC 
and returned to normal by 32 h PC (Figure 5). Rectal temperatures started to increase at 2 h PC, and 
this increase was significantly (P<0.01) more pronounced in EL than in LL between 2 and 4 h PC. 
The peak temperature occurred at 8 h PC, being on average 40.3˚C in EL and 40.1˚C in LL. Severe 
or moderate local signs were present in the udder already at 2 h PC, peaking at 4 h PC  
*** *** *
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(Figure 5). Changes in milk appearance followed local signs in the quarters (Figure 5): milk turned 
serous and yellow on average at 8 h PC in EL and at 4 h PC in LL. More severe changes in milk 
appearance were seen in LL than in EL, but individual variation was substantial. The severity of 
systemic signs varied more than that of local signs between cows and lactation stages. 
 
 
 
Figure 5. Change in systemic and local signs and milk appearance of cows after induction of endotoxin 
mastitis.  Data points represent the average (±SE) of nine cows. Values in early lactation are indicated with 
solid symbols and lines, and those in late lactation with open symbols and dashed lines. 
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Only mild changes in milk appearance occurred in the control quarters. Daily milk yield decreased 
in most cows on the first day after challenge, on average 18% in EL and 35% in LL. The milk yield 
returned to baseline levels on the second day in EL and on the third day in LL.  
 
 
8.2.2. Serum and milk parameters (IV) 
Prechallenge values for serum biochemistry and milk inflammatory parameters were generally 
similar between cows in EL and LL. Significant differences were found only for milk yield, serum 
urea and FFA concentration (Table 7).  
 
Table 7. Initial values of parameters studied in nine dairy cows in early and late lactation. A significant 
difference between columns is indicated with an asterisk. 
 
 Early lactation Late lactation 
Parameter Average SD Average SD 
     
Temperature (ºC) 38.6 0.20 38.7 0.37 
Heart rate (/min) 83 13.6 82 11.2 
Milk yield (kg/24 h) 27.7*** 6.2 13.8 4.6 
SCC (x103/ml) 37 29.4 83 163.9 
NAGase (AU3) 22 6.7 15 15.7 
WBC (x106/ml) 7.98 1.49 7.83 1.67 
Neutrophils (x106/ml) 3.53 1.33 3.05 1.01 
Lymphocytes (x106/ml) 3.06 0.58 3.48 0.81 
Haematocrite (%) 34.7 1.6 32.6 2.9 
Ca2+ (mmol/l) 1.31 0.13 1.28 0.09 
ASAT (u/l) 89 16.7 73 20.2 
Urea (mmol/l) 3.6* 0.71 4.6 0.61 
Creatine (µmol/l) 90 9.7 88 5.2 
FFA (mEq/l) 0.37*** 0.14 0.16 0.04 
Cortisol (nmol/l) 11.36 8.82 10.90 10.17 
CL in milk (RLU/1000 cells) 0 0 0 0 
CL in blood (RLU/1000 cells) 0.12 0.06 0.13 0.04 
TNFα in milk (µg/ml) 0 0 0 0 
TNFα in serum (µg/ml) 0 0 0 0 
SAA in milk (µg/ml) 0.34 0.5 0.3 0.6 
SAA in serum (µg/ml) 13.01 13.63 16.77 20.49 
 
SCC = somatic cell count 
NAGase = N-acetyl-β-D-glucosaminidase 
AU = Arbitrary units  
WBC = White blood cell count  
ASAT = Serum aspartate aminotransferase activity 
FFA = Free fatty acids 
CL = chemiluminescence 
RLU = relative light unit 
TNFα = Tumour necrosis factor alpha 
SAA = Serum amyloid A 
*P<0.05 
***P<0.001  
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In the endotoxin-infused quarter, milk SCC clearly started to increase at 2 h PC, reaching a 
maximum at 8-24 h PC (Figure 6). Milk NAGase activity followed the increase of SCC, peaking at 
12 h PC at 320 AU in EL and 269 AU in LL cows. EL cows had a significantly (P<0.05) higher 
SCC than LL cows. NAGase levels were also higher in EL, but the difference was not significant. 
SCC and NAGase did not return to baseline levels during the experimental period. Milk SCC and 
NAGase from the control quarters stayed within the normal range in both EL and LL. 
 
The white blood cell (WBC) count changed significantly (P<0.001) during the experiment. At 4 h 
PC, the WBC count was its lowest, at 5.3 x 106 cells/ml in EL and 5.2 x 106 cells/ml in LL. The 
peak WBC count, 13.3 x 106 cells/ml and 9.4 x 106 cells/ml, was seen at 24 h PC in EL and at 32 h 
PC in LL, respectively. The difference in the average levels of WBC between EL and LL was 
significant (P<0.01), being higher in EL. The number of blood neutrophils also changed 
significantly (P<0.001) during the experiment for both EL and LL, and was significantly (P<0.01) 
different between EL and LL cows (Figure 7). After 4 h PC, the increase in the neutrophil count 
was more pronounced in EL than in LL, remaining higher until 32 h PC. In addition, the number of 
blood lymphocytes changed markedly (P<0.001) during the experiment for both lactation stages 
(Figure 7). At 8 and 12 h PC, the number of lymphocytes was lower in EL than in LL. While the 
PCV changed significantly (P<0.001) during the experiment, the values stayed within normal 
ranges.  
 
Serum cortisol changed significantly (P<0.001) during the experiment, reaching peak values at 4 h 
PC (mean values 134.8 nmol/l in EL and 156.4 nmol/l in LL) and returning to baseline levels after 
12 h PC. No significant differences were seen between the levels in EL and LL. Concentrations of 
serum urea, FFA, creatinine and ASAT also showed significant (P<0.001) changes during the 
experiment, but the values stayed within the normal range. The concentrations of serum FFA were 
markedly (P<0.001) higher and serum urea significantly (P<0.05) lower in EL than in LL 
throughout the study. The changes in blood Ca2+ levels were not significant. 
 
 
8.2.2.1. Neutrophil function (IV) 
After the endotoxin challenge, the CL of blood neutrophils started to decrease in EL and increase in 
LL (Figure 7), whereas in the milk CL increased in both EL and LL (Figure 6). The increase was 
more prominent in EL, although the differences were not statistically significant. CL changes 
during the experiment were not significantly different from baseline for either blood or milk.  
 
 
8.2.2.2. Tumour necrosis factor alpha (V) 
No detectable levels of TNFα in serum were found at any time-point. The concentration of TNFα in 
milk began to increase after the endotoxin infusion, peaking at 8 h PC (Figure 6). The peak 
concentration was higher in EL than in LL, at an average of 111.9 ng/ml vs. 33.9 ng/ml, although 
the difference was not significant at any time-point between lactation stages.  
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Figure 6. Changes in milk somatic cell count, chemiluminescence  and concentrations of TNFα and serum 
amyloid A in milk after induction of endotoxin mastitis. Data points represent the average (±SE) of nine 
cows. Values in early lactation are indicated with solid symbols and solid lines, and those in late lactation 
with open symbols and dashed lines. 
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Figure 7. Changes in blood neutrophils and lymphocytes, chemiluminescence, and concentration of serum 
amyloid A in serum after induction of endotoxin mastitis. Data points represent the average (±SE) of nine 
cows. Values in early lactation are indicated with solid symbols and solid lines, and those in late lactation 
with open symbols and dashed lines. 
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8.2.2.3. Serum amyloid A (V) 
Intramammary endotoxin caused a highly significant (P<0.001) increase in both serum and milk 
SAA concentrations. Initial values were on average 14.9 (range 2.1-67.1) µg/ml in serum and close 
to the lower detection limit (0.3 µg/ml) in milk; no significant differences between EL and LL were 
seen. The concentrations started to increase after 8 h PC, peaking at 32 h PC in milk (Figure 6) and 
at 48 h PC in serum (Figure 7). Compared with prechallenge values, SAA concentration in serum 
was significantly higher after 24 h PC in EL (P<0.001) and after 12 h PC in LL (P<0.05). In milk, 
significantly higher values were seen already after 8 h PC in EL (P<0.05) and after 24 h PC in LL 
(P<0.05). 
 
The individual time-concentration curves of SAA in serum were similar in EL and LL. The average 
peak concentration at 48 h PC was significantly (P<0.05) higher in LL than in EL (Figure 7), at 
244.3 µg/ml and 193.5 µg/ml, respectively.  
 
In milk, SAA concentrations were higher in EL than in LL (Figure 6). Between 12 and 24 h PC, the 
SAA concentrations increased significantly (P<0.05) more in EL than in LL, and statistically 
different values were seen at 24 h (P<0.01) and 32 h PC (P<0.05). The average peak concentrations 
were 424.6 µg/ml in EL and 185.8 µg/ml in LL at 32 h PC. 
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9. DISCUSSION 
 
 
Pathogenesis of bacterial infection involves a complicated interaction between bacterial and host 
factors. In most E. coli infections, the pathogenicity of the bacterial strain is obligatory to this 
interaction and defines the course of the disease. Mastitis caused by E. coli seems to differ from 
other E. coli infections in its pathogenesis. A normal healthy udder is free from all pathogens. 
Invasion of infective agents activates a host response and clinical signs appear. E. coli mastitis 
differs from other E. coli infections because the clinical signs are primarily caused by the host 
response and not by the pathological changes derived from bacterial toxins and other damaging 
factors.  
 
Several previous studies have been published about the initiation, severity and outcome of E. coli  
mastitis, and the possible effects of different bacterial and host factors. Strong evidence shows that 
E. coli mastitis is not caused by a limited number of strains with certain specific characteristics but 
by a great variety of strains arising from the environment of the cow (Linton et al., 1979; Linton and 
Robinson, 1984; Sanchez-Carlo et al., 1984b; Valente et al., 1988; Lipman et al., 1995; Jung, 1999). 
Moreover, the cow’s host response has been demonstrated to be a key factor in determining 
susceptibility to E. coli mastitis (Burvenich et al., 2003). Our study confirms earlier results which 
have indicated that E. coli isolates from clinical bovine mastitis possess a variety of different 
virulence factors but that these factors are not common. None of the virulence factors found here 
was associated with disease severity.  
 
Among all 273 E. coli isolates studied, 66% had a gene for some virulence factor or were resistant 
to serum. Different virulence factors were distributed widely, and 29 different combinations of 
virulence factors were detected, including different groups of serum resistance. This is in agreement 
with earlier results which have suggested that no special virulence characteristics are commonly 
present among E. coli strains isolated from mastitis (Table 1). To infect the bovine udder, specific 
virulence factors, e.g. those enhancing adhesion or invasion in the epithelia or damaging host cells, 
seem not to be necessary for E. coli bacteria. For the pathogenesis of E. coli mastitis, the only 
essential event appears to be the release of endotoxin, which initiates a host response in mastitis but 
has no direct toxic effect (Cullor, 1996; Hogan and Smith, 2003). 
 
Adhesion and invasion of bacteria to the host epithelia is considered the first event in bacterial 
infections. Different fimbriae and adhesins are crucial to the pathogenicity of E. coli strains, causing 
diarrhoea and urinary infections. In cattle populations, E. coli with F17 fimbriae are very common. 
In Finland, 49% of healthy calves or calves with diarrhoea carry E. coli strains positive for fimbrial 
adhesins, such as F17 fimbriae, in the intestine (T. Pohjanvirta, personal communication). Afimbrial 
adhesins are also found from E. coli isolated from intestinal and extraintestinal sources of cattle 
(Bouguénec and Bertin, 1999). For example, S and P fimbriae are important in adhesion of 
uropathogenic E. coli strains (Soto and Hultgren, 1999).  
 
In E. coli isolated from mastitis, only Lipman et al. (1995) and Stephan and Kuhn (1999) have 
shown the presence of genes coding fimbriae production (Table 1). Adhesion or attachment of 
bacteria to the mammary epithelium is not considered important in the pathogenesis of the disease 
(Opdebeek et al., 1988). Our findings support this since less than 10% of all isolates were positive 
to any fimbriae or adhesins studied.  Prevalence of the genes for F17-related fimbriae was only 9% 
in the Finnish strains and 1% in the Israeli strains. The S and P fimbriae were generally found 
together in the Finnish isolates, 7.5% being positive for S fimbriae and 7% for P fimbriae. Of the 
Israeli isolates, only one was positive for S fimbriae, and none of the isolates had P fimbriae. Two 
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groups of afimbrial adhesins were also tested, Afa and CS31A. These were rare in the isolates 
studied here; genes for Afa7 or CS31A were not found at all, and only two Finnish isolates 
possessed the gene for Afa8.  
 
Toxin production is another common virulence factor of E. coli. After colonization, some strains 
produce toxins that have a deleterious effect on host cells, disturbing their functions. Production of 
CNF2 is common among bovine E. coli strains. The prevalence of CNF-positive E. coli strains 
among isolates from healthy cattle is 30-45% (Pohl et al., 1993; Burns et al., 1996), and from 
healthy calves and calves with diarrhoea, 71% and 61%, respectively (T. Pohjanvirta, a personal 
communication). Only one CNF2-producing E. coli strain has previously been reported in relation 
to mastitis (Pohl et al., 1993), indicating that toxin production may not be involved in the disease 
pathogenesis. However, the number of E. coli isolates used to determine CNF2 production has been 
low, in total only 91 isolates (Table 1). In our material, CNF2 was the second most common 
virulence factor among Finnish strains and present in the most frequently detected combinations; 
altogether 27 of the155 strains were CNF2-positive. CNF1 is far less prevalent in bovine E. coli 
strains (Burns et al., 1996). In our study, only 13 of the 155 isolates were positive for CNF1. 
 
Other E. coli virulence factors connected with the survival of bacteria in the host and acting against 
the host defence systems have also been studied (Table 1). Different siderophores are important for 
E. coli, chelating iron for subsequent bacterial use. In mammary infections, this ability is thought to 
be more important than in other infections since milk contains lactoferrin, which also chelates iron 
and efficiently inhibits the growth of Gram-negative bacteria. Lin et al. (1998) found all isolates 
from bovine intramammary infections to be positive for siderophore production. In other studies, 
less than 20% have been positive for the most extensively studied siderophore, aerobactin (Linggod 
et al., 1987; Nemeth et al., 1994). We found only 8.4% of the isolates to be positive for aerobactin, 
11% of Finnish and less than 5% of Israeli isolates (Table 6), suggesting that the prevalence differs 
geographically. Another siderophore, enterobactin, has a higher affinity for iron than aerobactin 
(Bagg and Neilands, 1987) and may be more important in mastitis, especially during the dry period, 
when the amount of iron is lower. 
 
Serum resistance has earlier been considered an obligatory virulence factor for mastitis-causing E. 
coli bacteria (Carroll and Jasper, 1977). Some later studies have also reported serum-sensitive 
isolates from naturally occurring mastitis cases (Nemeth et al., 1991, 1994; Fang and Pyörälä, 
1996). In our study, 41% of all isolates were serum-resistant and 16% serum-sensitive. These 
results show that sensitive isolates are more common than suggested earlier (Carroll and Jasper, 
1977; Sanchez-Carlo et al., 1984a; Barrow and Hill, 1989; Nemeth et al., 1991, 1994; Fang and 
Pyörälä, 1996). According to previous studies, infections caused by serum-resistant isolates were 
more severe than those caused by serum-sensitive isolates (Carroll et al., 1973; Barrow and Hill, 
1989). In our study, the Finnish isolates were more resistant to serum, which was unexpected, as E. 
coli mastitis in Israel is usually more severe than that seen in Finland (Shpigel et al., 1994; 
Sandholm and Pyörälä, 1995). Our findings make the significance of serum resistance in the 
pathogenesis of E. coli mastitis questionable. The bacteria killing ability of serum is based on the 
activation of the complement system. The amount of complement in milk has been speculated to be 
too low to cause bacterial lysis (Rainard, 2003). In E. coli mastitis, both the classical and alternative 
pathways of complement activation are important (Hogan et al., 1989). The killing ability of serum 
not only depends on the serum sensitivity of the isolate but also on the production of different host-
derived complement factors and antibodies (Rainard, 2003).  
 
The outer membrane protein TraT is a common virulence factor found in E. coli isolated from 
healthy and diseased animals (Sukupolvi and O´Connors, 1990; Nemeth et al., 1991). In our study, 
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this was the virulence factor most frequently detected, with 38% of all isolates being TraT-positive. 
This finding is in agreement with results reported by Nemeth et al. (1991). TraT is supposed to play 
an important role in the serum resistance of bacteria (Sukupolvi and O´Connors, 1990). However, in 
Nemeth et al. (1991), 32% of mastitis strains were TraT-positive and serum-resistant, but no 
association was found between TraT and serum resistance. In our study, these traits appeared to be 
associated, as 44.7% of serum-resistant isolates were also positive for TraT, whereas only 27.3% of 
serum-sensitive isolates were TraT-positive. Similar proportions were found when the Finnish and 
Israeli isolates were concidered separately. 
 
All virulence factors but TraT were rare in Israeli isolates. This striking difference between the two 
countries is interesting. Differences between geographical areas have also been reported earlier. E. 
coli strains positive for CS31A, for instance, were found less frequently in Argentina than in the 
countries of the Nordic hemisphere (Mercado et al., 2003). In the Netherlands, 55% of isolates from 
bovine mastitis expressed F17-related fimbriae (Nemeth et al., 1994; Lipman et al., 1995), which is 
far more than in our study. Difference between countries or even herds may be caused by different 
management systems. In Finland, calves are kept together with cows, thus sharing the same pool of 
bacteria, whereas in Israel they are strictly separated and bacterial exchange is unlikely. E. coli 
isolates from faeces of healthy and diarrhoeic calves frequently possess virulence factors F17 and 
CNF2 (T. Pohjanvirta, a personal communication). Different management practices of herds may 
explain the differences seen in the proportions of these virulence factors between countries, Israeli 
E. coli isolates may, of course, have some other virulence factors not studied here. 
 
The E. coli isolates were divided into two major groups based on composition and genetic location 
of their virulence factor genes. Genes for F17-related fimbriae, CNF2, Afa and TraT, which are 
located on plasmids (Sukupolvi and O’Connors, 1990; Falbo et al., 1992; le Bouguenec and Bertin, 
1999; Mainil et al., 1999), were found together in isolates, and these strains formed one major 
group. The other major group contained the genes for CNF1 and S and P fimbriae, which are 
located chromosomally (Falbo et al., 1992; Mainil et al., 1997, 1999). These genes were always 
found in combination, consistent with previous reports (Bertin et al., 1998). Genes for aerobactin, 
located on either a chromosome or plasmid, could belong to either group.  
 
 Altogether 27% of isolates were resistant to one or more antimicrobial agents. Most common was 
resistance to tetracycline, which accounted for 15% of all isolates. This is still a relatively low 
figure compared with other published studies, in which the proportion of resistant isolates has 
ranged from 26% to 74% (Sogaard, 1982; Anderson, 1989; Trolldenier, 1995; Anonymous, 2001; 
Erskine et al., 2002a). In our study, 11% of all isolates were multiresistant. All but one 
multiresistance pattern included resistance to tetracycline, which is often associated with resistance 
to other antimicrobials (Orden et al., 2000; Österbland et al., 2000; Oppegaard et al., 2001; Tibbets 
et al., 2003). Several studies on E. coli strains of animal origin have found an association between 
tetracycline-, ampicillin- or multiresistance and possession of such virulence factors as enterobactin, 
aerobactin, colicin, F5, F41, F17, CNF, verotoxin and eae gene (Orden et al., 2000; Johnson et al., 
2002; Tibbets et al., 2003). Nemeth et al. (1991) also found a positive correlation between TraT and 
resistance to ampicillin, streptomycin, sulphamethoxale and tetracycline in mastitis-causing E. coli  
isolates. By contrast, in a study on E. coli originating from septicaemic foals, aerobactin was not 
connected to antimicrobial resistance (Hirsh et al., 1993). In our study, resistance to tetracycline 
was associated with presence of virulence factors S and P fimbriae, CNF1, CNF2, aerobactin and 
TraT. A link was also found between ampicillin resistance and aerobactin, as well as between DHS 
resistance and CNF2, F17 and aerobactin. Although resistance to tetracycline was associated with 
the virulence genes located in chromosomes (Bertin et al., 1996), resistance is more likely to be 
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transmitted by plasmids and to be associated with genes located in that plasmid, such as aerobactin 
and CNF2. 
 
As the genes for virulence factors partly reside in the same plasmids as the genes for antimicrobial 
resistance (Levy, 1992; Prescott, 2000), it is possible that the use of antimicrobials selects for 
certain virulence factors together with resistance to antimicrobial agents. Some studies have shown 
that the use of antibiotics has directly contributed to an increased prevalence of resistance 
(Aarestrup, 1999; Anonymous, 2001). Multiresistant bacteria also tend to maintain their resistance 
to a particular antimicrobial, even when that antimicrobial is absent from the environment, if the 
other factors to which the resistance is linked are still present (Levy, 1992; Prescott, 2000; Galland 
et al., 2001).  
 
The use of antimicrobial agents in dairy herds is controlled in both Finland and Israel. 
Antimicrobials are used for cattle for therapeutic purposes only, and subtherapeutic or growth-
promoting use is not allowed. This may be relevant to the interpretation of our results, especially 
since the more resistant strains of E. coli are suggested to originate from calves, due to their greater 
exposure to antibiotics (Linton et al., 1979). The controlled use of antimicrobials could be one 
reason for the low level of resistance found here, compared with other studies (Bishop et al., 1980; 
Sogaard, 1982; Anderson, 1989; Trolldenier, 1995; Erskine et al., 2002a). However, because most 
studies have used different methods for susceptibility testing, comparisons should be made with 
caution.  
 
We found no association between virulence factors and severity of mastitis in the Finnish material. 
One reason for this could be that very severe cases were missing from the Finnish material. Because 
clinical signs and outcome of E. coli mastitis have been shown to be more severe in Israel compared 
with Finland (Shpigel et al., 1994; Pyörälä and Pyörälä, 1998), if bacterial virulence factors had a 
significant effect on the severity of the disease, they would have been more common among Israeli 
strains, which they were not. On the other hand, the Israeli cows may have more stress factors than 
Finnish cows due to the hotter climate, more intensive management, much bigger herd size and 
higher milk production. The amount of E. coli in the environment of the cow is probably higher in 
an Israeli managing system than in Finland. For these reasons, the cows in Israel could generally be 
at greater risk and more susceptible to E. coli infections. One could then hypothesize that in Israel 
any E. coli strain might cause mastitis, whereas in Finland due to perhaps more resistant cows, only 
the more virulent E. coli strains cause mastitis. Two studies have shown that the production of 
different virulence factors among E. coli strains isolated from mastitis and from faeces of healthy 
cows is similar (Carroll and Jasper, 1977; Nemeth et al., 1994). Mastitis-causing E. coli are known 
to originate from the environment of the cow and their virulence probably reflects the situation of 
bacteria found in the intestines or faeces of the cow. Based on previous studies (Carroll et al., 1973; 
Carroll and Jasper, 1977; Linton et al., 1979; Linton and Robinson, 1984; Sanchez-Carlo et al., 
1984b; Valente et al., 1988; Barrow, 1989; Nemeth et al., 1994; Lipman et al., 1995; Jung, 1999) 
and our own results, we conclude that the virulence factors of the infecting bacterial strain probably 
play a minor role in the severity of clinical signs of E. coli mastitis.   
 
However, some evidence indicates that the outcome of E. coli mastitis may be related to some 
characteristics of the infecting bacterial strain. Previous studies have suggested the existence of 
udder-adapted E. coli strains, which could produce chronic or recurrent E. coli mastitis (Lipman et 
al., 1995; Lam et al., 1996a; Döpfer et al., 1999; Bradley and Green, 2001). Recurrent cases tended 
to be milder than non-recurrent cases, which could favour the persistence of bacteria in the udder 
(Bradley and Green, 2001). In our study, presence of genes for S and P fimbriae was significantly 
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associated with persistence of mastitis. In humans, E. coli with S and P fimbriae is associated with 
recurrent cases of urinary tract infections (Schilling et al., 2001). 
 
Definition of persistent infection in recurrent E. coli mastitis is difficult. Fingerprinting techniques 
are useful to identify the strains and our study would have benefited from the use of those 
techniques. Same E. coli genotypes have been found in recurrent cases of mastitis, but in some 
studies 63% were of different genotypes (Döpfer et al., 1999) or serotypes (Linton and Robinson, 
1984). However, even if identical strains would be detected, they could be those predominating in 
the cow’s environment, and the possibility of reinfection cannot be excluded. In addition, in earlier 
research as well as in our study, the cases were not followed up throughout the study period, which 
would be necessary to confirm the real persistence of infection. 
 
Host response has a major role in coliform mastitis, and the clinical course and final outcome of the 
disease is mostly based on the reactions of the host, the cow. Different physiological factors have a 
substantial effect, the most important being parity and lactation stage of the cow. We did not study 
the effect of cows’ age on host response, but evidence from earlier studies has shown that young 
cows are more resistant than older cows due to their more alert defence mechanisms (van Werven et 
al., 1997; Mehrzad et al., 2002b). 
 
Lactation stage greatly affects the susceptibility of the cow to E. coli infections, and early-lactating 
cows are the most susceptible (Burvenich et al., 2003; Hogan and Smith, 2003). During the dry 
period, when the lactoferrin concentration in milk is high, clinical E. coli mastitis seldom occurs. 
Some E. coli strains can, however, produce siderophores to survive in a low iron environment (Lin 
et al., 1998, 1999) and therefore may infect the cow (Bradley and Green, 2000). If E. coli mastitis is 
detected during the dry period, it usually occurs 1-2 weeks before calving, when the udder is no 
longer fully involuted and colostrogenesis has started (Smith et al., 1985; Bradley and Green, 2000). 
In a fully involuted udder, spontaneous coliform mastitis is rare (Smith et al., 1985), and induction 
of experimental E. coli infection has failed (Todhunter et al., 1990).  
 
Cows are known to be most susceptible to coliform mastitis during the puerperial period (Kehrli et 
al., 1989; Kremer et al., 1990; Shuster et al., 1996; Mehrzad et al., 2002b; Hogan and Smith, 2003). 
There are several reasons for this phenomenon; at this stage, the metabolic state of the cow does not 
favour efficient defence, and stress around parturition, which is related to high cortisol levels, 
interferes with cellular defence (Breazile, 1988). Our field data showed an increased incidence 
during the post-partum period, as E. coli mastitis was most common in EL (0-21 days PP), 
decreasing towards the dry period.  
 
During the puerperial period and EL, cows suffering from mastitis due to E. coli have more severe 
clinical signs than cows in LL (Hill et al., 1979; Pyörälä and Pyörälä, 1998; Mehrzad et al., 2002b). 
This was also seen in our experimental endotoxin study. However, in our field data, the clinical 
signs unexpectedly tended to be milder in EL (0-21 days PP) than in LL. This may reflect the 
difficulty of defining severity in spontaneous mastitis. In the field, mastitis may be diagnosed by the 
herd owner about 12 h after onset of infection (Lohuis et al., 1990b; Hirvonen et al., 1999; Hoeben, 
1999; Haddad et al., 2001). If veterinary consultation is sought, the diagnosis is made several hours 
later. Assessment of the severity of spontaneous coliform mastitis in practice occurs relatively late 
in the course of the disease, after, for example, the fever peak has already passed. This may be one 
reason for the milder clinical signs often reported in naturally occurring coliform mastitis than in 
experimental studies (Haddad et al., 2001).  
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The severity of the response of cows in E. coli mastitis varies markedly between individuals 
(Vandeputte-Van Messom et al., 1993; Hirvonen et al., 1999). One explanation for this individual 
variation may be the different sensitivity of cows to environmental stressors, as increased stress and 
rise of plasma cortisol are associated with a decreased number of circulating lymphocytes (Hopster 
et al., 1998). In our endotoxin experiment, the same cows were used in the studies during EL and 
LL to minimize the effect of individual variation and to determine the actual impact of lactation 
period. The cortisol levels of the cows in EL and LL did not differ significantly. While a cow-to-
cow variation was clearly seen, the difference between EL and LL was greater than the difference 
between individual cows.  
 
The ability of the immune system of the cow to resist bacterial invasion is critical in determining 
cows’ the susceptibility to E. coli mastitis. Efficacy of host defence also defines how severe the 
course of mastitis will be. Although the host response is an extremely complicated network of 
different actions and components, the number and function of PMN in blood and especially in milk 
are critical (Burvenich et al., 2003). The initial number of PMN in blood and milk have been shown 
to correlate negatively with the severity of E. coli mastitis (Vandeputte-Van Messom et al., 1993; 
Shuster et al., 1996; Dosogne et al., 1997). In healthy cows, the number of PMN is lower in EL than 
in LL (Kehrli et al., 1989; Kulberg et al., 2002). A slightly lower initial number of blood PMN and 
milk SCC in EL than in LL were also seen in our study. A low number of PMN in milk may cause 
inefficient killing of bacteria, thus allowing them to rapidly multiply (Shuster et al., 1996). 
Simultaneously with an increase in milk SCC at 4 h PC, the number of circulating PMN in blood 
decreased (Figures 6 and 7), a phenomenon well known from other studies (Hoeben, 1999; 
Bannerman et al., 2003). Blood neutropenia caused by the migration of PMN to the infection site of 
the udder (Paape et al., 1974) is resolved by releasing both mature and immature neutrophils from 
bone marrow (Hoeben, 1999). In our study, PMN numbers in milk and blood increased faster and 
reached higher levels in EL cows than in LL cows. This could be due to a greater PMN recruitment 
during EL, as has earlier been shown in experimental E. coli mastitis (Shuster et al., 1996). The 
number of PMN in blood and milk thus may not be the reason for the increased susceptibility of EL 
cows to E. coli mastitis. PMN function may be more critical to host defence than their actual 
number (Lohuis et al., 1990a; Cai et al., 1994; Cooray and Håkansson, 1995; Mehrzad, 2002a). In 
experimental E. coli infection, bacteria multiplied at a significantly higher rate in milk of cows with 
low PMN respiratory burst activity (Vandeputte-van Messom et al., 1993; Mehrzad, 2002a). PMN 
function and respiratory burst activity are down-regulated by the onset of apoptosis (van Oostveld et 
al., 2002). This could be one reason for the decreased PMN functions seen in the peripartum period 
since during this time the rate of apoptosis is increased (van Oostveld et al., 2001). If the production 
of ROS is not adequately regulated, the respiratory burst and ROS production may become harmful 
to the host, resulting in tissue damage and increasing the severity of clinical response (Burvenich et 
al., 2003). In the puerperal period and EL, PMN ROS production may be extracellular, causing 
inadequate bacterial killing and more damage to the udder tissue (Mehrzad, 2002a; Burvenich et al., 
2003).  
 
Function of milk and blood PMN measured as CL has been reported to be significantly lower in EL 
than in LL in healthy cows (Hoeben et al., 2000b; Mehrzad et al., 2001b). A lower preinfection 
respiratory burst was associated to lower glucose, magnesium, calcium and cortisol levels and 
higher FFA levels in blood of cows (Vandeputte-van Messom et al., 1993). ROS production of 
blood PMN was lower in cows with higher fat infiltration in the liver at 7-10 days PP (Zerbe et al., 
2000). In our study, no difference was found in preinfection CL levels between EL and LL cows. 
This could be due to the different methods used; we used zymosan-induced CL, which also 
measures phagocytosis and not only respiratory burst, as does PMA-induced CL, which was used in 
the studies of the other authors (Hoeben et al., 2000b; Mehrzad et al., 2001b). Phagocytosis of PMN 
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is known not to be depressed in EL (Dosogne, 1998). We found that the initial CL was lower in 
milk cells than in blood cells, a finding also reported earlier (Mehrzad et al., 2001a). The lower CL 
of milk PMN after zymosan induction may be caused by prestimulation of milk PMN by the milk 
components and exhaustion of the cells (Paape et al., 2003). Phagocytosis may also be impaired due 
to the limited energy reserves in milk (Paape et al., 2003). 
 
After the endotoxin challenge, the function of blood neutrophils measured as CL increased in LL 
but decreased in EL. The reason for the decreased CL after parturition and during E. coli infections 
has been suggested to be due to the increased proportion of immature neutrophils in blood 
(Dosogne, 1998). Immature neutrophils have been shown to have an impaired respiratory burst 
ability (Glasser and Fiederlein, 1987). In our study, a low CL was seen simultaneously with 
neutropenia, when immature neutrophils are not yet released. In addition, as mentioned earlier, 
zymosan-induced CL measures not only respiratory burst of PMN but also their capacity for 
phagocytosis (Hoeben, 1999), which is already present at an early stage of PMN maturation 
(Glasser and Fiederlein, 1987). One explanation for the impaired CL in blood PMN could be 
subclinical ketosis of the cow (Hoeben et al., 1997; Suriyasathaporn et al., 2000; Zerbe et al., 2000), 
reflected by increased serum FFA concentrations in EL cows (Burvenich et al., 1994; Jorritsma et 
al., 2001; Nikolic et al., 2003), as also seen in our study. 
 
The CL of milk PMN increased in both EL and LL after the endotoxin challenge. The increase in 
CL of milk during both lactation periods appeared at the same time as SCC increased. The increase 
was more pronounced in EL, appearing simultaneously with the decreased CL of PMN in blood. 
This may result from an influx of the most active PMN from the circulation to the milk (Dosogne, 
1998). The milk cells achieved a higher CL than blood neutrophils, supporting the finding of 
Mehrzad et al. (2001a). This could be due to the local production of proinflammatory mediator 
TNFα and other cytokines that trigger PMN functions (Paape et al., 2003).  
 
TNFα was detected in the milk, but not in the serum of cows in both EL and LL. In previous 
studies, TNFα has been detected in the plasma and milk of early-lactating cows (Blum et al., 2000; 
Hoeben et al., 2000a) but not in cows in mid-lactation (Paape et al., 2002). Levels of TNFα have 
been much higher in milk than in serum (Sordillo and Peel, 1992; Nakajima et al., 1997; Hirvonen 
et al., 1999; Blum et al., 2000; Hoeben et al., 2000a; Hisaeda et al., 2001; Ohtsuka et al., 2001; 
Paape et al., 2002). In the milk of our cows, TNFα concentration was higher in EL cows, although 
the difference was not significant because of the great variation between individuals (Figure 6). 
Increased TNFα production around the time of calving has also been found by others. Periparturient 
dairy cows have been reported to have an increased number of monocytes and macrophages with 
increased expression of the membrane receptor mCD14, which may enhance the capacity of these 
cells to secrete TNFα in vitro (Sordillo et al., 1995; Røntved et al., 2004). EL and LL cows may 
also have differences in the amount of soluble sCD14 receptors. An increased amount of sCD14 
decreases the amount of TNFα because it binds the LPS-LBP complex instead of mCD14, which 
otherwise would lead to release of TNFα from macrophages (Lee et al., 2003; Wang et al., 2003). 
Recruitment of neutrophils increases, leading to a faster clearance of bacteria, and thus, milder 
clinical signs (Lee et al., 2003). 
 
We found TNFα production to peak at 8 h PC, when SCC had also reached its highest level. This is 
in accordance with previous evidence that milk cells are the main source of TNFα, although during 
inflammation mammary epithelial cells may also produce some TNFα (Pfaffl et al., 2003). The 
TNFα concentration in milk does not increase before the manifestation of clinical signs but is 
detected at the same time as the systemic signs and later than the local signs (Blum et al., 2000; 
Hoeben et al., 2000a; Lee et al., 2003). After intramammary and intraveous infusion of endotoxin, 
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the concentration of TNFα in the blood was found to increase later than body temperature or many 
of the metabolic changes, indicating that these signs are not mediated by circulating TNFα (Werling 
et al., 1996; Steiger et al., 1999; Hoeben et al., 2000a). Although TNFα production has generally 
been shown to peak in milk simultaneously or later than clinical signs, small amounts of TNFα have 
been detected shortly after endotoxin challenge (Persson Waller et al., 1997; Hoeben et al., 2000a). 
TNFα appears to have a critical role in initiating host response by inducing the local production of  
IL-1, IL-6 and IL-8 (Watanabe et al., 2000; Paape et al., 2002; Wang et al., 2003), which in turn 
mediate the systemic effects of the host response (Van Miert, 1991; Shuster et al., 1993). TNFα also 
has other roles in the local reaction. In vitro studies have shown the stimulating effect of bovine 
recombinant TNFα on neutrophil functions (Chiang et al., 1991; Sample and Czuprynski, 1991). 
Locally active TNFα and IL-1 may also activate the expression and action of matrix 
metalloproteinase (MMP) (Hanemaaljes et al., 1997). The metalloproteinases MMP2 and MMP9 
were found to peak at 2-4 h after endotoxin challenge, 2 h before the SCC increase in milk, and 
were suggested to enhance vascular permeability, enabling the invasion of PMN into the milk (Li et 
al., 1999; Raulo et al., 2002). TNFα has usually only been detected in blood of cows with very 
severe mastitis (Pedersen et al., 2003). The positive correlation between severity of host reaction 
and concentration of TNFα in blood or milk seen in previous studies (Hirvonen et al., 1999; Blum et 
al., 2000; Hisaeda et al., 2001; Ohtsuka et al., 2001) may be due to the abnormal regulation of a 
normal TNFα-mediated response (Burvenich et al., 2003). The effect of TNFα may become 
deleterious to the host when its production is excessively high (Lee et al., 2003) or when production 
does not cease sufficiently early. 
 
Production of acute-phase proteins, such as SAA and haptoglobin, at a later stage of the host 
response is related to the repair processes after tissue damage, detoxification of LPS (Urieli-Shoval 
et al., 2000) and down-regulation of pro-inflammatory responses (Uhlar and Whitehead, 1999). In 
our study, SAA increased in both serum and milk after alleviation of clinical signs. When clinical 
signs were the most intense, the SAA concentration in milk had reached only one-fourth of its 
highest value. These early-phase concentrations of SAA were similar to those found by Eckersall et 
al. (2001) in spontaneous clinical mastitis. SAA peaked earlier in milk than in serum, but the levels 
of SAA in serum did not follow those of milk. This supports the idea that SAA must be produced 
and regulated both locally and systemically (Eckersall et al., 2001; McDonald et al., 2001). TNFα 
was not found in serum which indicates that in cattle systemic SAA production is not induced by 
TNFα but by some other cytokines, such as IL-6, which increase in the serum after LPS stimulation 
or during E. coli mastitis (Shuster et al., 1993; Werling et al., 1996; Nakajima et al., 1997). The 
cytokine IL-6 has been shown to be a potent inducer of hepatic production of SAA (Alsemgeest et 
al., 1996). In milk, the concentrations of TNFα and SAA seemed to be closely related; cows with 
very low TNFα levels also had low SAA concentrations, and those with high TNFα levels had high 
SAA concentrations. A positive correlation between TNFα and SAA has also been observed in 
human patients with sepsis (Uhlar and Whitehead, 1999). Locally produced SAA may also induce 
the production of TNFα and other cytokines by neutrophils (Furlaneto and Campa, 2000). 
 
TNFα and SAA concentrations in milk and serum have been suggested to correlate with the severity 
of the cow’s response (Sordillo et al., 1995; Hirvonen et al., 1999; Blum et al., 2000; Eckersall et 
al., 2001; Hisaeda et al., 2001; Ohtsuka et al., 2001). Changes in milk appearance during mastitis 
are partly caused by loosened cell connections in the udder epithelia, allowing passage of proteins, 
enzymes, cells and trace elements between milk and blood. Thus, because of the increased 
permeability between milk and blood compartments of the udder, some of the SAA detected in the 
serum may originate from milk. This may also explain the trace amounts of TNFα detected in serum 
in some studies. Here, more severe systemic and local signs were seen in EL cows, which also had 
higher average concentrations of TNFα and SAA in milk. SAA concentrations in serum, by 
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contrast, were lower in EL than in LL. One reason for this could be the compromised function of 
hepatocytes during the peripartum period due to a fatty liver, resulting in decreased production of 
SAA. 
 
The results here support previous observations that increased susceptibility of the cow to E. coli 
mastitis and more severe disease course during EL depend more on host factors than on bacterial 
properties. The virulence and antimicrobial resistance of mastitis-causing E. coli reflect the situation 
of bacteria in the environment or in the intestines or faeces of the cow. To prevent of E. coli 
mastitis, more efforts should be directed at improving the cow’s environment and herd 
management. Although the literature on bovine E. coli mastitis is abundant, knowledge on its 
pathogenesis remains far from complete. Further studies should focus on host response and other 
cow factors related in this complex disease. Especially cytokine and interleukin interaction at the 
early stage of host response as well as the role of APP in the inflammation process should be 
investigated. One advantage of E. coli mastitis research is that good infection and inflammation 
challenge models are available; our cross-over study design diminishes the cow-to-cow variation. 
Field studies on spontaneous mastitis are also necessary to confirm findings of experimental 
research. For improved comparisons between different studies, the definitions of clinical E. coli 
mastitis characteristics (mild, moderate, severe, persistent) should be standardized. A deeper 
understanding of E. coli mastitis pathogenesis may help us to improve the immune defence of dairy 
cows against coliform mastitis and to develop more effective treatments. 
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10. CONCLUSIONS 
 
 
1. E. coli isolates from clinical bovine mastitis in Finland and Israel possessed a variety of 
different virulence factors, but none of these was common. To infect the bovine udder, specific 
virulence factors do not seem to be necessary for E. coli bacteria. 
 
2. The differences in prevalence of virulence factors and in clinical signs of E. coli mastitis in 
both Finland and Israel suggest that the virulence factors of the bacterial strain probably play a 
minor role in the severity of E. coli mastitis.   
 
3. The presence of genes for S and P fimbriae, CNF1 and CNF2 was significantly associated with 
persistence of mastitis. Recurrent E. coli mastitis could be caused by udder-adapted E. coli 
strains, and the outcome from E. coli mastitis may be related to certain characteristics of the 
bacterial strain. 
 
4. Antimicrobial resistance of E. coli isolates was low; 27% of the isolates were resistant to one 
or more antimicrobial agents and 11% were multiresistant. All but one multiresistance pattern 
included resistance to tetracycline. Associations between tetracycline resistance and S and P 
fimbriae, CNF1, CNF2, aerobactin and TraT, ampicillin resistance and aerobactin, and DHS 
resistance and CNF2, F17 and aerobactin were found.  
 
5. In the experimental endotoxin mastitis, cows showed more severe systemic signs in EL than in 
LL.  
 
6. TNFα concentration in milk increased after the endotoxin challenge, reaching higher levels in 
EL. In blood, no TNFα was detected. TNFα may not be directly responsible for the systemic 
signs in endotoxin mastitis, but it probably has a critical role in initiating the host response. 
TNFα also seems to induce production of SAA in milk since the concentration of SAA in milk 
was higher in EL than in LL, and the concentrations of TNFα and SAA were closely related at 
the cow level. In blood, SAA increased later than in milk after endotoxin challenge, and the 
average concentration was higher in LL, indicating differences in production and regulation of 
local and systemic SAA. 
 
7. After induction of endotoxin mastitis, PMN numbers in milk and blood increased faster and 
reached higher levels in EL than in LL. However, the function of blood neutrophils, measured 
as CL, increased in LL but decreased in EL after the endotoxin challenge. This impaired 
function of blood PMN in EL could be caused by subclinical ketosis of the cow, reflected in 
increased serum FFA concentrations. The CL of milk PMN increased in both EL and LL, 
being more pronounced in EL and appearing simultaneously with the decreased CL of PMN in 
blood. This could have resulted from an influx of the most active PMN from the circulation to 
the milk, and from the stimulation of milk PMN by locally produced cytokines such as TNFα. 
The function of PMN may therefore be more critical for host defence and for susceptibility of 
cows to E. coli mastitis than their actual number in blood and milk. 
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